Live Oak Bancshares (LOB) 10-Q 13 Nov 15 2015 Q3 Quarterly report Financial data

Document and Entity Information

Document and Entity Information - shares	9 Months Ended
	Sep. 30, 2015	Nov. 12, 2015
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Sep. 30, 2015
Document Fiscal Year Focus	2,015
Document Fiscal Period Focus	Q3
Trading Symbol	LOB
Entity Registrant Name	Live Oak Bancshares, Inc.
Entity Central Index Key	1,462,120
Current Fiscal Year End Date	--12-31
Entity Filer Category	Non-accelerated Filer
Voting Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		29,447,381
Nonvoting Common Stock [Member]
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		4,723,530

Consolidated Balance Sheets (Un

Consolidated Balance Sheets (Unaudited) - USD ($) $ in Thousands		Sep. 30, 2015	Dec. 31, 2014
Assets
Cash and due from banks		$ 129,881	$ 29,902	[1]
Certificates of deposit with other banks		10,000	10,000	[1]
Investment securities available-for-sale		51,628	49,318	[1]
Loans held for sale		443,871	295,180	[1]
Loans held for investment		259,552	203,936	[1]
Allowance for loan losses		(6,153)	(4,407)	[1]
Net loans		253,399	199,529	[1]
Premises and equipment, net		62,641	35,279	[1]
Foreclosed assets		48	371	[1]
Servicing assets		40,590	34,999	[1]
Investments in non-consolidated affiliates	[1]		6,345
Other assets		20,708	12,392	[1]
Total assets		1,012,766	673,315	[1]
Deposits:
Noninterest-bearing		20,365	14,728	[1]
Interest-bearing		742,263	507,352	[1]
Total deposits		762,628	522,080	[1]
Short term borrowings	[1]		6,100
Long term borrowings		42,079	41,849	[1]
Other liabilities		13,963	11,472	[1]
Total liabilities		818,670	581,501	[1]
Shareholders' equity
Retained earnings (accumulated deficit)		7,108	(6,943)	[1]
Accumulated other comprehensive income		87	85	[1]
Total shareholders' equity attributed to Live Oak Bancshares, Inc.		194,062	91,814	[1]
Noncontrolling interest		34
Total equity		194,096	91,814	[1]
Total liabilities and shareholders' equity		$ 1,012,766	$ 673,315	[1]
Non-cumulative Perpetual Preferred Stock (Series A) [Member]
Shareholders' equity
Preferred stock				[1]
Preferred Stock Undefined [Member]
Shareholders' equity
Preferred stock				[1]
Class A Common Stock [Member]
Shareholders' equity
Common stock		$ 136,852	$ 48,657	[1]
Class B Common Stock [Member]
Shareholders' equity
Common stock		$ 50,015	$ 50,015	[1]
[1]	Derived from audited consolidated financial statements.

Consolidated Balance Sheets (U3

Consolidated Balance Sheets (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2015	Dec. 31, 2014	[1]
Non-cumulative Perpetual Preferred Stock (Series A) [Member]
Preferred stock, shares authorized	6,800	6,800
Preferred stock, shares issued	6,800	6,800
Preferred stock, shares outstanding	6,800	6,800
Preferred Stock Undefined [Member]
Preferred stock, no par value
Preferred stock, shares authorized	1,000,000	1,000,000
Preferred stock, shares issued	0	0
Preferred stock, shares outstanding	0	0
Class A Common Stock [Member]
Common stock, no par value
Common stock, shares authorized	100,000,000	100,000,000
Common stock, shares issued	29,443,970	23,896,400
Common stock, shares outstanding	29,443,970	23,896,400
Class B Common Stock [Member]
Common stock, no par value
Common stock, shares authorized	10,000,000	10,000,000
Common stock, shares issued	4,723,530	4,723,530
Common stock, shares outstanding	4,723,530	4,723,530
[1]	Derived from audited consolidated financial statements.

Consolidated Statements of Inco

Consolidated Statements of Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Interest income
Loans and fees on loans	$ 8,704	$ 5,189	$ 22,811	$ 14,040
Investment securities, taxable	211	93	587	292
Other interest earning assets	84	38	220	102
Total interest income	8,999	5,320	23,618	14,434
Interest expense
Deposits	1,997	1,172	5,274	3,401
Borrowings	395	254	1,280	611
Total interest expense	2,392	1,426	6,554	4,012
Net interest income	6,607	3,894	17,064	10,422
Provision for loan losses	1,212	512	2,339	1,411
Net interest income after provision for loan losses	5,395	3,382	14,725	9,011
Noninterest income
Loan servicing revenue and revaluation	1,566	3,230	7,444	9,515
Net gains on sales of loans	15,424	13,108	46,604	35,465
Equity in loss of non-consolidated affiliates		(177)	(26)	(2,379)
Gain on sale of investment in non-consolidated affiliate			3,782
Gain on sale of investment securities available-for-sale	12		12
Other noninterest income	768	342	2,144	1,215
Total noninterest income	17,770	16,503	59,960	43,816
Noninterest expense
Salaries and employee benefits	9,949	6,120	27,623	21,828
Travel expense	2,180	1,791	5,852	3,879
Professional services expense	597	1,758	2,129	3,364
Advertising and marketing expense	1,051	763	3,177	2,283
Occupancy expense	699	518	1,887	1,384
Data processing expense	773	730	2,388	1,787
Equipment expense	584	433	1,338	999
Other expense	2,206	1,154	5,132	3,726
Total noninterest expense	18,039	13,267	49,526	39,250
Income before taxes	5,126	6,618	25,159	13,577
Income tax expense	2,228	5,977	10,272	5,977
Net income	2,898	641	14,887	7,600
Net loss attributable to noncontrolling interest	3		23
Net income attributable to Live Oak Bancshares, Inc.	$ 2,901	$ 641	$ 14,910	$ 7,600
Basic earnings per share	$ 0.09	$ 0.03	$ 0.50	$ 0.34
Diluted earnings per share	$ 0.09	$ 0.02	$ 0.48	$ 0.33

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (Unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Statement of Comprehensive Income [Abstract]
Net income	$ 2,898	$ 641	$ 14,887	$ 7,600
Other comprehensive income (loss) before tax:
Net unrealized gain (loss) on investment securities arising during the period	151	(11)	15	192
Reclassification adjustment for (gain) loss on sale of securities available-for-sale included in net income	(12)		(12)
Other comprehensive income (loss) before tax	139	(11)	3	192
Income tax expense	(53)		(1)
Other comprehensive income (loss), net of tax	86	(11)	2	192
Total comprehensive income	$ 2,984	$ 630	$ 14,889	$ 7,792

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (Unaudited) - USD ($) $ in Thousands	Total		Common Stock [Member]	Common Stock [Member]Class A Common Stock [Member]	Common Stock [Member]Class B Common Stock [Member]	Retained Earnings (accumulated deficit) [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Noncontrolling Interest [Member]
Beginning balance at Dec. 31, 2013	$ 48,390		$ 18,319			$ 30,262	$ (191)
Beginning balance, shares at Dec. 31, 2013				20,318,330
Net income (loss)	7,600					7,600
Other comprehensive income	192						192
Reclass from redeemable equity securities	3,605		3,605
Sales of common stock	200		200
Sales of common stock, shares				45,440
Stock option exercises	$ 177		177
Stock option exercise, shares	191,660			191,660
Issuance of common stock grants	$ 2,992		2,992
Issuance of common stock grants, shares				685,700
Common stock issued in private placement, net of offering cost	74,631		74,631
Common stock issued in private placement, net of offering cost, shares				2,324,770	4,723,530
Debt conversion to common stock	3,052		3,052
Debt conversion to common stock, shares				287,020
Stock option based compensation expense	112		112
Reclassification adjustment for change in taxable status			(5,123)			5,123
Restricted stock expense	143		143
Dividends (distributions to shareholders)	(44,150)					(44,150)
Ending balance at Sep. 30, 2014	96,944		98,108			(1,165)	1
Ending balance, shares at Sep. 30, 2014				23,852,920	4,723,530
Beginning balance at Dec. 31, 2014	91,814	[1]	98,672			(6,943)	85
Beginning balance, shares at Dec. 31, 2014				23,896,400	4,723,530
Net income (loss)	14,887					14,910		$ (23)
Other comprehensive income	2						2
Consolidation of investment with non-controlling interest	35							35
Stock option exercises	$ 215		215
Stock option exercise, shares	47,570			47,570
Stock option based compensation expense	$ 726		726
Restricted stock expense	83		83
Capital contribution from non-controlling interest	22							22
Issuance of common stock in connection with initial public offering, net of issue costs	87,171		87,171
Issuance of common stock in connection with initial public offering, net of issue costs, shares				5,500,000
Dividends (distributions to shareholders)	(859)					(859)
Ending balance at Sep. 30, 2015	$ 194,096		$ 186,867			$ 7,108	$ 87	$ 34
Ending balance, shares at Sep. 30, 2015				29,443,970	4,723,530
[1]	Derived from audited consolidated financial statements.

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (Unaudited) $ in Thousands	9 Months Ended
	Sep. 30, 2015USD ($)		Sep. 30, 2014USD ($)
Cash flows from operating activities
Net income	$ 14,887		$ 7,600
Adjustments to reconcile net income to net cash used by operating activities:
Depreciation and amortization	1,917		1,612
Provision for loan losses	2,339		1,411
Amortization of premium on securities, net of accretion	36		69
Amortization (accretion) of discount (premium) on unguaranteed loans, net	1,650		(376)
Deferred tax expense	936		3,253
Originations of loans held for sale	(740,378)		(531,717)
Proceeds from sales of loans held for sale	508,322		391,626
Net loss on sale of foreclosed assets	12
Net increase in servicing assets	(5,591)		(6,046)
Net gains on sale of loans held for sale	(46,604)		(35,465)
Gain on sale of securities available-for-sale	(12)
Gain on sale of investment in non-consolidated affiliate	(3,782)
Net loss (gain) on disposal of premises and equipment	16		(256)
Stock option based compensation expense	726		112
Restricted stock expense	83		143
Stock grants			2,992
Equity in loss of non-consolidated affiliates	26		2,379
Changes in assets and liabilities:
Accounts receivable and other assets	(2,269)		(2,620)
Accrued expenses and other liabilities	2,025		12,198
Net cash used by operating activities	(265,661)		(153,085)
Cash flows from investing activities
Purchases of securities available-for-sale	(15,437)		(31,482)
Proceeds from sales, maturities, calls, and principal paydowns of securities available-for-sale	13,106		1,875
Proceeds from sale of foreclosed assets	352
Investment in certificates of deposit			(9,250)
Investments in non-consolidated affiliates			(6,114)
Proceeds from sale of investment in non-consolidated affiliate	9,896
Capital investments in non-consolidated affiliates			(500)
Net cash acquired in consolidation of equity method investment	319
Capital contribution from non-controlling interest	22
Loan originations and principal collections, net	66,835		53,415
Proceeds from sale of premises and equipment			2,200
Purchases of premises and equipment, net	(29,295)		(11,303)
Net cash provided (used) by investing activities	45,798		(1,159)
Cash flows from financing activities
Net increase in deposits	240,548		85,990
Proceeds from long term borrowings	12,960		20,305
Repayment of long term borrowings	(12,730)		(2,447)
Proceeds from short term borrowings			15,066
Repayment of short term borrowings	(6,100)
Stock option exercises	215		177
Sale of common stock, net	87,171		74,831
Shareholder dividend distributions	(2,222)		(38,280)
Net cash provided by financing activities	319,842		155,642
Net increase in cash and cash equivalents	99,979		1,398
Cash and cash equivalents, beginning	29,902	[1]	37,244
Cash and cash equivalents, ending	129,881		38,642
Supplemental disclosure of cash flow information
Interest paid	6,501		3,970
Income tax	11,312		3,253
Supplemental disclosures of noncash operating, investing, and financing activities
Unrealized holding gains on available-for-sale securities, net of taxes	2		192
Conversion of convertible subordinated debt into common stock			3,052
Transfers from loans to foreclosed real estate and other repossessions	700		327
Transfers from foreclosed real estate to SBA receivable	659		289
Transfers of loans accounted for as secured borrowing collateral to other assets	4,575
Transfer of loans held for sale to loans held for investment	7,410		8,937
Transfer of loans held for investment to loans held for sale	2,129		16,428
Contingent consideration in acquisition of controlling interest in equity method of investment	$ 170
Non-cash dividend			$ 9,514
[1]	Derived from audited consolidated financial statements.

Basis of Presentation

Basis of Presentation	9 Months Ended
	Sep. 30, 2015
Accounting Policies [Abstract]
Basis of Presentation	Note 1. Basis of Presentation Nature of Operations Live Oak Bancshares, Inc. (the “Company” or “LOB”) is a bank holding company headquartered in Wilmington, North Carolina incorporated under the laws of North Carolina in December 2008. The Company conducts business operations primarily through its commercial bank subsidiary, Live Oak Banking Company (the “Bank”). The Bank was established in May 2008 as a North Carolina-chartered commercial bank. The Bank specializes in providing lending services to small businesses nationwide in targeted industries. The Bank identifies and grows within credit-worthy industries through expertise within those industries. A significant portion of the loans originated by the Bank are guaranteed by the Small Business Administration (“SBA”) under the 7(a) program. In 2010, the Bank formed Live Oak Number One, Inc., a wholly-owned subsidiary, to hold properties foreclosed on by the Bank. On July 23, 2015 the Company closed on its initial public offering. In addition to the Bank, the Company owns Independence Aviation, LLC, which was formed for the purpose of purchasing and operating aircraft used for business purposes of the Company, Live Oak Grove, LLC, opened in September 2015 for the purpose of providing Company employees and business visitors an on-site restaurant location, Government Loan Solutions, Inc. (“GLS”), a management and technology consulting firm that specializes in the settlement, accounting, and securitization processes for government guaranteed loans, including loans originated under the SBA 7(a) loan program and USDA-guaranteed loans, and 504 Fund Advisors, LLC (“504FA”), formed to serve as the investment advisor to the 504 Fund, a closed-end mutual fund organized to invest in SBA section 504 loans. The Company acquired control over 504FA, previously carried as an equity method investment, on February 2, 2015 by increasing its ownership from 50.0% to 91.3%. The acquisition of an additional 41.3% of ownership occurred in exchange for contingent consideration estimated to total $170 thousand. Transactions in the third quarter of 2015 increased the Company’s ownership to 92.4%. With 7.6% of ownership remaining with a third party investor, amounts of earnings and equity in 504FA attributable to the third party investor are now disclosed in the Company’s consolidated financial statements as related to a noncontrolling interest. The Company earns revenue primarily from the sale of SBA-guaranteed loans. This income is comprised of net gains on the sale of loans, revenues on the servicing of sold loans and valuation of loan servicing rights. Net interest income is another contributor to earnings. Offsetting these revenues are the cost of funding sources, provision for loan losses, any costs related to foreclosed assets and other operating costs such as salaries and employee benefits, travel, professional services, advertising and marketing and tax expense. General In the opinion of management, all adjustments necessary for a fair presentation of the financial position and results of operations for the periods presented have been included, and all intercompany transactions have been eliminated in consolidation. Results of operations for the nine months ended September 30, 2015 are not necessarily indicative of the results of operations that may be expected for the year ending December 31, 2015. The consolidated balance sheet as of December 31, 2014 has been derived from the audited consolidated financial statements contained in the Company’s registration statement on Form S-1 (File No. 333-205126), as amended. A summary description of the significant accounting policies followed by the Company is set forth in Note 1 of the Notes to Consolidated Financial Statements in the Company’s registration statement on Form S-1, as amended. The preparation of financial statements in conformity with United States generally accepted accounting principles, or GAAP, requires management to make estimates and assumptions that affect reported amounts of assets and liabilities and the reported amounts of revenues and expenses during the reporting period. Actual results could differ significantly from those estimates. Amounts in all tables in the Notes to Unaudited Consolidated Financial Statements have been presented in thousands, except percentage, time period, stock option, share and per share data. Stock Split On September 23, 2014, the Board of Directors declared a ten-for-one stock split of the Company’s Class A and Class B common shares, which was effected in the form of a common stock dividend distributed on October 10, 2014. Except for the amount of authorized shares, all references to share and per share amounts in the consolidated financial statements and accompanying notes to the consolidated financial statements have been retroactively restated to reflect the stock split. Business Segments Management has determined that the Company has one significant operating segment, which is providing a lending platform for small businesses nationwide. In determining the appropriateness of segment definition, the Company considers the materiality of a potential segment, the components of the business about which financial information is available, and components for which management regularly evaluates relative to resource allocation and performance assessment. Reclassifications Certain reclassifications have been made to the prior period’s consolidated financial statements to place them on a comparable basis with the current year. Net income and shareholders’ equity previously reported were not affected by these reclassifications.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2015
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	Note 2 - Recent Accounting Pronouncements In January 2015, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update No. 2015-01, “Simplifying Income Statement Presentation by Eliminating the Concept of Extraordinary Items” (“ASU 2015-01”). ASU 2015-01 eliminated from U.S. GAAP the concept of an extraordinary item, which is an event or transaction that is both unusual in nature and infrequently occurring. The guidance will be effective for the Company for interim and annual reporting periods beginning after December 15, 2015. Early adoption is permitted. The Company does not expect this guidance to have a material effect on its consolidated financial statements. In February 2015, the FASB issued Accounting Standards Update No. 2015-02, “Amendments to the Consolidation Analysis” (“ASU 2015-02”). ASU 2015-02 amended the consolidation requirements in Accounting Standards Codification (“ASC”) 810 Consolidation In April 2015, the FASB issued ASU 2015-05, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) – Customer’s Accounting for Fees Paid in a Cloud Computing Arrangement.” ASU 2015-05 addresses accounting for fees paid by a customer in cloud computing arrangements such as (i) software as a service, (ii) platform as a service, (iii) infrastructure as a service and (iv) other similar hosting arrangements. ASU 2015-05 provides guidance to customers about whether a cloud computing arrangement includes a software license. If a cloud computing arrangement includes a software license, then the customer should account for the software license element of the arrangement consistent with the acquisition of other software licenses. If a cloud computing arrangement does not include a software license, the customer should account for the arrangement as a service contract. ASU 2015-05 will be effective for the Company on January 1, 2016 and is not expected to have a significant impact on its consolidated financial statements. In May 2015, the FASB issued ASU 2015-07, “Fair Value Measurement (Topic 820): Disclosures for Investments in Certain Entities that Calculate Net Asset Value per Share (or its Equivalent) (a Consensus of the Emerging Issues Task Force).” The new guidance eliminates the requirement to classify in the fair value hierarchy any investments for which fair value is measured at net asset value per share using the practical expedient. This guidance is effective for interim and annual periods beginning after December 15, 2015. The adoption of this guidance is not expected to be material to the consolidated financial statements. In September 2015, the FASB issued ASU 2015-16, “Business Combinations (Topic 805) – Simplifying the Accounting for Measurement-Period Adjustments.” ASU 2015-16 requires that adjustments to provisional amounts that are identified during the measurement period of a business combination be recognized in the reporting period in which the adjustment amounts are determined. Furthermore, the income statement effects of such adjustments, if any, must be calculated as if the accounting had been completed at the acquisition date. The portion of the amount recorded in current-period earnings that would have been recorded in previous reporting periods if the adjustment to the provisional amounts had been recognized as of the acquisition date. Under previous guidance, adjustments to provisional amounts identified during the measurement period are to be recognized retrospectively. ASU 2015-16 will be effective for the Company on January 1, 2016 and is not expected to have a significant impact on the consolidated financial statements. Live Oak Bancshares, Inc. Notes to Unaudited Consolidated Financial Statements

Earnings Per Share

Earnings Per Share	9 Months Ended
	Sep. 30, 2015
Earnings Per Share [Abstract]
Earnings Per Share	Note 3. Earnings Per Share Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company. Three Months Ended Nine Months Ended 2015 2014 2015 2014 Basic earnings per share: Net income available to common shareholders $ 2,901 $ 641 $ 14,910 $ 7,600 Weighted-average basic shares outstanding 32,824,587 25,632,505 30,037,436 22,412,646 Basic earnings per share $ 0.09 $ 0.03 $ 0.50 $ 0.34 Diluted earnings per share: Net income available to common shareholders, for diluted earnings per share $ 2,901 $ 641 $ 14,910 $ 7,600 Total weighted-average basic shares outstanding 32,824,587 25,632,505 30,037,436 22,412,646 Add effect of dilutive stock options and restricted stock grants 1,092,695 603,195 892,794 286,789 Total weighted-average diluted shares outstanding 33,917,282 26,235,700 30,930,230 22,699,435 Diluted earnings per share $ 0.09 $ 0.02 $ 0.48 $ 0.33 Anti-dilutive shares 1,391,828 328,210 1,562,168 328,210 Pro forma earnings per share Because the Company was not a taxable entity prior to August 3, 2014, pro forma amounts for income tax expense and basic and diluted earnings per share have been presented below assuming the Company’s effective tax rate of 38.5% for the three and nine months ended September 30, 2014. Three Months Ended Nine Months Ended Pro forma net income available to common shareholders, after tax $ 4,071 $ 8,349 Pro forma basic earnings per share $ 0.16 $ 0.37 Pro forma diluted earnings per share $ 0.16 $ 0.37 Live Oak Bancshares, Inc. Notes to Unaudited Consolidated Financial Statements

Securities

Securities	9 Months Ended
	Sep. 30, 2015
Investments, Debt and Equity Securities [Abstract]
Securities	Note 4. Securities The carrying amount of securities and their approximate fair values are reflected in the following table: Amortized Unrealized Unrealized Fair September 30, 2015 US government agencies $ 26,987 $ 226 $ — $ 27,213 Residential mortgage-backed securities 22,570 32 136 22,466 Mutual fund 1,930 19 — 1,949 $ 51,487 $ 277 $ 136 $ 51,628 December 31, 2014 US government agencies $ 35,207 $ 127 $ 25 $ 35,309 Residential mortgage-backed securities 13,973 92 56 14,009 $ 49,180 $ 219 $ 81 $ 49,318 During the three months ended September 30, 2015, the Company sold three US government agency securities for $8.3 million at a gain of $12 thousand and purchased four mortgage-backed securities totaling $9.5 million in a transaction designed to enhance cashflow and yield. In addition, during the first and second quarters of 2015, the Company sold six mortgage-backed securities at their carrying amount for $3.4 million in an odd-lot consolidation and purchased two mortgage-backed securities for $4.0 million for the purpose of complying with the Community Reinvestment Act. The Company also invested $1.9 million in the 504 Fund mutual fund. The investment in this mutual fund was purchased at current market value (190,380.762 shares at $9.98 per share). During the nine months ending September 30, 2015, there was $30 thousand of dividend reinvestment in the 504 Fund mutual fund as well. There were no calls or maturities of securities during the three and nine months ending September 30, 2015. During the three months and nine months ended September 30, 2014, there were purchases of five US government agency securities for $29.9 million as part of a strategic investment plan to utilize excess cash from the $74.6 million private placement capital raise that took place in August 2014 and one mortgage-backed security purchased for $1.6 million for the purpose of complying with the Community Reinvestment Act. There were no calls, sales or maturities of securities during the three and nine months ended September 30, 2014. The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position. Less Than 12 Months 12 Months or More Total September 30, 2015 Fair Unrealized Fair Unrealized Fair Unrealized Residential mortgage-backed securities $ 14,453 $ 114 $ 3,269 $ 22 $ 17,722 $ 136 Total $ 14,453 $ 114 $ 3,269 $ 22 $ 17,722 $ 136 Less Than 12 Months 12 Months or More Total December 31, 2014 Fair Unrealized Fair Unrealized Fair Unrealized US government agencies $ — $ — $ 1,224 $ 25 $ 1,224 $ 25 Residential mortgage-backed securities 2,234 4 5,158 52 7,392 56 Total $ 2,234 $ 4 $ 6,382 $ 77 $ 8,616 $ 81 At September 30, 2015, there were three mortgage-backed securities in unrealized loss positions for greater than 12 months and nine mortgage-backed securities in unrealized loss positions for less than 12 months. Unrealized losses at December 31, 2014, were comprised of six securities, consisting of one US government agency security and five mortgage-backed securities, in unrealized loss positions for greater than 12 months and one mortgage-backed security in an unrealized loss position for less than 12 months. These unrealized losses are primarily the result of volatility in the market and are related to market interest rates. Since none of the unrealized losses relate to marketability of the securities or the issuer’s ability to honor redemption obligations, none of the securities are deemed to be other than temporarily impaired. All residential mortgage-backed securities in the Company’s portfolio at September 30, 2015 and December 31, 2014 were backed by US government sponsored enterprises (“GSEs”). The following is a summary of investment securities by maturity: September 30, 2015 Available-for-sale Amortized Fair One to five years $ 26,987 $ 27,213 Five to ten years 10,052 10,057 After 10 years 12,518 12,409 $ 49,557 $ 49,679 The table above reflects contractual maturities. Actual results will differ as the loans underlying the mortgage-backed securities may repay sooner than scheduled. This table excludes the 504 Fund mutual fund investment. At September 30, 2015 and December 31, 2014, investment securities with a fair market value of $1.3 million were pledged to secure a line of credit with the Company’s correspondent bank. Live Oak Bancshares, Inc. Notes to Unaudited Consolidated Financial Statements

Loans and Allowance for Loan Lo

Loans and Allowance for Loan Losses	9 Months Ended
	Sep. 30, 2015
Receivables [Abstract]
Loans and Allowance for Loan Losses	Note 5. Loans and Allowance for Loan Losses Loan Portfolio Segments The following describes the risk characteristics relevant to each of the portfolio segments. Each loan category is assigned a risk grade during the origination and closing process based on criteria described later in this section. Commercial and Industrial Commercial and industrial loans (C&I) receive similar underwriting treatment as commercial real estate loans in that the repayment source is analyzed to determine its ability to meet cash flow coverage requirements as set forth by Bank policies. Repayment of the Bank’s C&I loans generally comes from the generation of cash flow as the result of the borrower’s business operations. This business cycle itself brings a certain level of risk to the portfolio. In some instances, these loans may carry a higher degree of risk due to a variety of reasons – illiquid collateral, specialized equipment, highly depreciable assets, uncollectable accounts receivable, revolving balances, or simply being unsecured. As a result of these characteristics, the SBA guarantee on these loans is an important factor in mitigating risk. Construction and Development Construction and development loans are for the purpose of acquisition and development of land to be improved through the construction of commercial buildings. Such loans are usually paid off through the conversion to permanent financing for the long-term benefit of the borrower’s ongoing operations. At the completion of the project, if the loan is converted to permanent financing or if scheduled loan amortization begins, it is then reclassified to the “Owner Occupied Commercial Real Estate” segment. Underwriting of construction and development loans typically includes analysis of not only the borrower’s financial condition and ability to meet the required debt obligations, but also the general market conditions associated with the area and type of project being funded. Owner Occupied Commercial Real Estate Owner occupied commercial real estate loans are extensions of credit secured by owner occupied collateral. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Such repayment of owner-occupied loans is commonly derived from the successful ongoing operations of the business occupying the property. These typically include small businesses and professional practices. Commercial Land Commercial land loans are extensions of credit secured by farmland. Such loans are often for land improvements related to agricultural endeavors that may include construction of new specialized facilities. These loans are usually repaid through the conversion to permanent financing, or if scheduled loan amortization begins, for the long-term benefit of the borrower’s ongoing operations. Underwriting generally involves intensive analysis of the financial strength of the borrower and guarantor, liquidation value of the subject collateral, the associated unguaranteed exposure, and any available secondary sources of repayment, with the greatest emphasis given to a borrower’s capacity to meet cash flow coverage requirements as set forth by Bank policies. Each of the loan types referenced in the sections above is further segmented into verticals in which the Bank chooses to operate. The Bank chooses to finance businesses operating in specific industries because of certain similarities. The similarities range from historical default and loss characteristics to business operations. However, there are differences that create the necessity to underwrite these loans according to varying criteria and guidelines. When underwriting a loan, the Bank considers numerous factors such as cash flow coverage, the credit scores of the guarantors, revenue growth, practice ownership experience and debt service capacity. Minimum guidelines have been set with regard to these various factors and deviations from those guidelines require compensating strengths when considering a proposed loan. Loans consist of the following: September 30, December 31, Commercial & Industrial Agriculture $ 30 $ — Death Care Management 4,831 3,603 Healthcare 13,563 12,319 Independent Pharmacies 41,123 34,079 Registered Investment Advisors 16,304 9,660 Veterinary Industry 20,985 20,902 Other Industries 1,216 494 Total 98,052 81,057 Construction & Development Agriculture 12,233 3,910 Death Care Management 991 92 Healthcare 7,722 2,957 Independent Pharmacies 687 215 Registered Investment Advisors 75 — Veterinary Industry 3,038 2,207 Other Industries 679 145 Total 25,425 9,526 Owner Occupied Commercial Real Estate Agriculture 125 259 Death Care Management 19,575 18,879 Healthcare 33,342 26,173 Independent Pharmacies 5,752 4,750 Registered Investment Advisors 2,981 2,161 Veterinary Industry 61,092 57,934 Other Industries 3,585 1,464 Total 126,452 111,620 Commercial Land Agriculture 9,354 1,248 Total 9,354 1,248 Total Loans 1 259,283 203,451 Net Deferred Costs 2,685 2,060 Discount on SBA 7(a) Unguaranteed 2 (2,416 ) (1,575 ) Loans, Net of Unearned $ 259,552 $ 203,936 1 Total loans include $21.8 million and $21.3 million of U.S. government guaranteed loans as of September 30, 2015 and December 31, 2014, respectively. 2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales. Credit Risk Profile The Bank uses internal loan reviews to assess the performance of individual loans by industry segment. An independent review of the loan portfolio is performed annually by an external firm. The goal of the Bank’s annual review of each borrower’s financial performance is to validate the adequacy of the risk grade assigned. The Bank uses a grading system to rank the quality of each loan. The grade is periodically evaluated and adjusted as performance dictates. Loan grades 1 through 4 are passing grades and grade 5 is special mention. Collectively, grades 6 through 8 represent classified loans in the Bank’s portfolio. The following guidelines govern the assignment of these risk grades: Exceptional Loans (1 Rated): These loans are of the highest quality, with strong, well-documented sources of repayment. Debt service coverage (“DSC”) is over 1.75X based on historical results. Secondary source of repayment is strong, with a loan to value (“LTV”) of 65% or less if secured solely by commercial real estate (“CRE”). Discounted collateral coverage from all sources should exceed 125%. Guarantors have credit scores above 740. Quality Loans (2 Rated): These loans are of good quality, with good, well-documented sources of repayment. DSC is over 1.25X based on historical or pro-forma results. Secondary source of repayment is good, with a LTV of 75% or less if secured solely by CRE. Discounted collateral coverage should exceed 100%. Guarantors have credit scores above 700. Acceptable Loans (3 rated): These loans are of acceptable quality, with acceptable sources of repayment. DSC of over 1.00X based on historical or pro-forma results. Companies that do not meet these credit metrics must be evaluated to determine if they should be graded below this level. Acceptable Loans (4 rated): These loans are considered very weak pass. These loans are riskier than a 3-rated credit, but due to various mitigating factors are not considered a Special Mention or worse. The mitigating factors must clearly be identified to offset further downgrade. Examples of loans that may be put in this category include start-up loans and loans with less than 1:1 cash flow coverage with other sources of repayment. Special mention (5 rated): These loans are considered as emerging problems, with potentially unsatisfactory characteristics. These loans require greater management attention. A loan may be put into this category if the Bank is unable to obtain financial reporting from a company to fully evaluate its position. Substandard (6 rated): Loans graded Substandard are inadequately protected by current sound net worth, paying capacity of the borrower, or pledged collateral. They typically have unsatisfactory characteristics causing more than acceptable levels of risk, and have one or more well-defined weaknesses that could jeopardize the repayment of the debt. Doubtful (7 rated): Loans graded Doubtful have inherent weaknesses that make collection or liquidation in full questionable. Loans graded Doubtful must be placed on non-accrual status. Loss (8 rated): Loss rated loans are considered uncollectible and of such little value that their continuance as an active Bank asset is not warranted. The asset should be charged off, even though partial recovery may be possible in the future. The following tables summarize the risk grades of each category: Risk Grades Risk Grade Risk Grades Total 1 September 30, 2015 Commercial & Industrial Agriculture $ 30 $ — $ — $ 30 Death Care Management 4,727 104 — 4,831 Healthcare 8,007 556 5,000 13,563 Independent Pharmacies 34,795 2,173 4,155 41,123 Registered Investment Advisors 15,952 352 — 16,304 Veterinary Industry 15,873 566 4,546 20,985 Other Industries 1,070 146 — 1,216 Total 80,454 3,897 13,701 98,052 Construction & Development Agriculture 12,141 92 — 12,233 Death Care Management 991 — — 991 Healthcare 7,722 — — 7,722 Independent Pharmacies 687 — — 687 Registered Investment Advisors 75 — — 75 Veterinary Industry 3,038 — — 3,038 Other Industries 679 — — 679 Total 25,333 92 — 25,425 Owner Occupied Commercial Real Estate Agriculture 125 — — 125 Death Care Management 17,041 832 1,702 19,575 Healthcare 28,804 1,716 2,822 33,342 Independent Pharmacies 5,355 397 — 5,752 Registered Investment Advisors 2,981 — — 2,981 Veterinary Industry 43,754 2,690 14,648 61,092 Other Industries 3,585 — — 3,585 Total 101,645 5,635 19,172 126,452 Commercial Land Agriculture 9,354 — — 9,354 Total 9,354 — — 9,354 Total $ 216,786 $ 9,624 $ 32,873 $ 259,283 Risk Grades Risk Grade Risk Grades Total 1 December 31, 2014 Commercial & Industrial Death Care Management $ 3,603 $ — $ — $ 3,603 Healthcare 6,995 538 4,786 12,319 Independent Pharmacies 27,673 2,726 3,680 34,079 Registered Investment Advisors 9,660 — — 9,660 Veterinary Industry 15,513 1,121 4,268 20,902 Other Industries 333 161 — 494 Total 63,777 4,546 12,734 81,057 Construction & Development Agriculture 3,910 — — 3,910 Death Care Management 92 — — 92 Healthcare 2,957 — — 2,957 Independent Pharmacies 215 — — 215 Veterinary Industry 2,207 — — 2,207 Other Industries 145 — — 145 Total 9,526 — — 9,526 Owner Occupied Commercial Real Estate Agriculture 259 — — 259 Death Care Management 16,519 639 1,721 18,879 Healthcare 22,778 938 2,457 26,173 Independent Pharmacies 4,709 41 — 4,750 Registered Investment Advisors 2,161 — — 2,161 Veterinary Industry 40,281 3,601 14,052 57,934 Other Industries 1,176 — 288 1,464 Total 87,883 5,219 18,518 111,620 Commercial Land Agriculture 1,248 — — 1,248 Total 1,248 — — 1,248 Total $ 162,434 $ 9,765 $ 31,252 $ 203,451 1 Total loans include $21.8 million of U.S. government guaranteed loans as of September 30, 2015, segregated by risk grade as follows: Risk Grades 1 – 4 = $0, Risk Grade 5 = $1.1 million, Risk Grades 6 – 8 = $20.7 million. As of December 31, 2014 total loans include $21.3 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $0, Risk Grade 5 = $1.1 million, Risk Grades 6 – 8 = $20.2 million. Past Due Loans Loans are considered past due if the required principal and interest payments have not been received as of the date such payments were due. Loans less than 30 days past due and accruing are included within current loans shown below. The following tables show an age analysis of past due loans as of the dates presented. Less Than 30 30-89 Days 30-89 Days Greater Total Not Current Total Loans Loans 90 September 30, 2015 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 30 $ 30 $ — Death Care Management — — — — — 4,831 4,831 — Healthcare — 277 — 2,321 2,598 10,965 13,563 — Independent Pharmacies 313 615 — 1,170 2,098 39,025 41,123 — Registered Investment Advisors — — — — — 16,304 16,304 — Veterinary Industry 114 110 646 2,257 3,127 17,858 20,985 — Other Industries — — — — — 1,216 1,216 — Total 427 1,002 646 5,748 7,823 90,229 98,052 — Construction & Development Agriculture — — — — — 12,233 12,233 — Death Care Management — — — — — 991 991 — Healthcare — 46 — — 46 7,676 7,722 — Independent Pharmacies — — — — — 687 687 — Registered Investment Advisors — — — — — 75 75 — Veterinary Industry — — — — — 3,038 3,038 — Other Industries — — — — — 679 679 — Total — 46 — — 46 25,379 25,425 — Owner Occupied Commercial Real Estate Agriculture — — — — — 125 125 — Death Care Management 1,479 — — — 1,479 18,096 19,575 — Healthcare — — — 2,308 2,308 31,034 33,342 — Independent Pharmacies — — — — — 5,752 5,752 — Registered Investment Advisors — — — — — 2,981 2,981 — Veterinary Industry 2,959 5,279 165 4,651 13,054 48,038 61,092 — Other Industries — — — — — 3,585 3,585 — Total 4,438 5,279 165 6,959 16,841 109,611 126,452 — Commercial Land Agriculture — — — — — 9,354 9,354 — Total — — — — — 9,354 9,354 — Total 1 $ 4,865 $ 6,327 $ 811 $ 12,707 $ 24,710 $ 234,573 $ 259,283 $ — Less Than 30 30-89 Days 30-89 Days Greater Total Not Current Total Loans Loans 90 December 31, 2014 Commercial & Industrial Death Care Management $ — $ — $ — $ — $ — $ 3,603 $ 3,603 $ — Healthcare — 1,059 232 2,420 3,711 8,608 12,319 — Independent Pharmacies — 98 — 1,224 1,322 32,757 34,079 — Registered Investment Advisors — — — — — 9,660 9,660 — Veterinary Industry 1,025 276 4 2,228 3,533 17,369 20,902 — Other Industries — — — — — 494 494 — Total 1,025 1,433 236 5,872 8,566 72,491 81,057 — Construction & Development Agriculture — — — — — 3,910 3,910 — Death Care Management — — — — — 92 92 — Healthcare — — — — — 2,957 2,957 — Independent Pharmacies — — — — — 215 215 — Veterinary Industry — — — — — 2,207 2,207 — Other Industries — — — — — 145 145 — Total — — — — — 9,526 9,526 — Owner Occupied Commercial Real Estate Agriculture — — — — — 259 259 — Death Care Management — — — 1,721 1,721 17,158 18,879 — Healthcare — 145 230 2,082 2,457 23,716 26,173 — Independent Pharmacies — — — — — 4,750 4,750 — Registered Investment Advisors — — — — — 2,161 2,161 — Veterinary Industry 2,464 5,101 1,951 2,836 12,352 45,582 57,934 — Other Industries — — — 275 275 1,189 1,464 — Total 2,464 5,246 2,181 6,914 16,805 94,815 111,620 — Commercial Land Agriculture — — — — — 1,248 1,248 — Total — — — — — 1,248 1,248 — Total 1 $ 3,489 $ 6,679 $ 2,417 $ 12,786 $ 25,371 $ 178,080 $ 203,451 $ — 1 Total loans include $21.8 million of U.S. government guaranteed loans as of September 30, 2015, of which $11.1 million is greater than 90 days past due, $3.1 million is 30-89 days past due and $7.6 million is included in current loans as presented above. As of December 31, 2014, total loans include $21.3 million of U.S. government guaranteed loans, of which $11.7 million is greater than 90 days past due, $3.5 million is 30-89 days past due and $6.1 million is included in current loans as presented above. Nonaccrual Loans Loans that become 90 days delinquent, or in cases where there is evidence that the borrower’s ability to make the required payments is impaired, are placed in nonaccrual status and interest accrual is discontinued. If interest on nonaccrual loans had been accrued in accordance with the original terms, interest income would have increased by approximately $358 thousand and $56 thousand for the three months ended September 30, 2015 and 2014, respectively, and for the nine months ended September 30, 2015 and 2014 interest income would have increased approximately $665 thousand and $147 thousand, respectively. All nonaccrual loans are included in the held for investment portfolio. Nonaccrual loans as of September 30, 2015 and December 31, 2014 are as follows: September 30, 2015 Loan Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 2,321 $ 2,136 $ 185 Independent Pharmacies 1,483 1,344 139 Veterinary Industry 3,017 2,979 38 Total 6,821 6,459 362 Owner Occupied Commercial Real Estate Death Care Management 1,479 1,309 170 Healthcare 2,308 1,990 318 Veterinary Industry 7,775 6,063 1,712 Total 11,562 9,362 2,200 Total $ 18,383 $ 15,821 $ 2,562 December 31, 2014 Loan Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 2,652 $ 2,368 $ 284 Independent Pharmacies 1,224 1,139 85 Veterinary Industry 3,257 3,113 144 Total 7,133 6,620 513 Owner Occupied Commercial Real Estate Death Care Management 1,721 1,505 216 Healthcare 2,312 1,919 393 Veterinary Industry 7,251 5,236 2,015 Other Industries 275 275 — Total 11,559 8,935 2,624 Total $ 18,692 $ 15,555 $ 3,137 Allowance for Loan Loss Methodology The methodology and the estimation process for calculating the Allowance for Loan Losses (“ALL”) is described below: Estimated credit losses should meet the criteria for accrual of a loss contingency, i.e., a provision to the ALL, set forth in GAAP. The Company’s methodology for determining the ALL is based on the requirements of GAAP, the Interagency Policy Statement on the Allowance for Loan and Lease Losses and other regulatory and accounting pronouncements. The ALL is determined by the sum of three separate components: (i) the impaired loan component, which addresses specific reserves for impaired loans; (ii) the general reserve component, which addresses reserves for pools of homogeneous loans; and (iii) an unallocated reserve component (if any) based on management’s judgment and experience. The loan pools and impaired loans are mutually exclusive; any loan that is impaired is excluded from its homogenous pool for purposes of that pool’s reserve calculation, regardless of the level of impairment. The ALL policy for pooled loans is governed in accordance with banking regulatory guidance for homogenous pools of non-impaired loans that have similar risk characteristics. The Company follows a consistent and structured approach for assessing the need for reserves within each individual loan pool. Loans are considered impaired when, based on current information and events, it is probable that the creditor will be unable to collect all interest and principal payments due according to the originally contracted, or reasonably modified, terms of the loan agreement. The Company has determined that loans that meet the criteria defined below must be reviewed quarterly to determine if they are impaired. • All commercial loans classified substandard or worse. • Any other delinquent loan that is in a nonaccrual status, or any loan that is delinquent more than 89 days and still accruing interest. • Any loan which has been modified such that it meets the definition of a Troubled Debt Restructuring (TDR). Any loan determined to be impaired is subjected to an impairment analysis, which is a calculation of the probable loss on the loan. This portion is the loan’s “impairment,” and is established as a specific reserve against the loan, or charged against the ALL. Individual specific reserve amounts imply probability of loss and may not be carried in the reserve indefinitely. When the amount of the actual loss becomes reasonably quantifiable, the amount of the loss is charged off against the ALL, whether or not all liquidation and recovery efforts have been completed. If the total amount of the individual specific reserve that will eventually be charged off cannot yet be sufficiently quantified but some portion of the impairment can be viewed as a confirmed loss, then the confirmed loss portion should be charged off against the ALL and the individual specific reserve reduced by a corresponding amount. For impaired loans, the reserve amount is calculated on a loan-specific basis. The Company utilizes two methods of analyzing impaired loans not guaranteed by the SBA: • The Fair Market Value of Collateral method utilizes the value at which the collateral could be sold considering the appraised value, appraisal discount rate, prior liens and selling costs. The amount of the reserve is the deficit of the estimated collateral value compared to the loan balance. • The Present Value of Future Cash Flows method takes into account the amount and timing of cash flows and the effective interest rate used to discount the cash flows. The following tables detail activity in the allowance for loan losses by portfolio segment allowance for the periods presented: Three months ended: Construction & Owner Commercial Commercial Total September 30, 2015 Beginning Balance $ 844 $ 2,346 $ 1,653 $ 340 $ 5,183 Charge offs — (7 ) (280 ) — (287 ) Recoveries — 12 33 — 45 Provision 336 (260 ) 830 306 1,212 Ending Balance $ 1,180 $ 2,091 $ 2,236 $ 646 $ 6,153 September 30, 2014 Beginning Balance $ 300 $ 1,931 $ 1,312 $ 25 $ 3,568 Charge offs — (227 ) (294 ) — (521 ) Recoveries — 5 13 — 18 Provision 159 316 (24 ) 61 512 Ending Balance $ 459 $ 2,025 $ 1,007 $ 86 $ 3,577 Nine months ended: Construction & Owner Commercial Commercial Total September 30, 2015 Beginning Balance $ 586 $ 2,291 $ 1,369 $ 161 $ 4,407 Charge offs — (128 ) (638 ) — (766 ) Recoveries — 100 73 — 173 Provision 594 (172 ) 1,432 485 2,339 Ending Balance $ 1,180 $ 2,091 $ 2,236 $ 646 $ 6,153 September 30, 2014 Beginning Balance $ 350 $ 1,511 $ 862 $ — $ 2,723 Charge offs — (346 ) (302 ) — (648 ) Recoveries — 72 19 — 91 Provision 109 788 428 86 1,411 Ending Balance $ 459 $ 2,025 $ 1,007 $ 86 $ 3,577 The following tables detail the recorded allowance for loan losses and the investment in loans related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology: September 30, 2015 Construction & Owner Commercial Commercial Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 1,032 $ 924 $ — $ 1,956 Loans collectively evaluated for impairment 1,180 1,059 1,312 646 4,197 Total allowance for loan losses $ 1,180 $ 2,091 $ 2,236 $ 646 $ 6,153 Loans receivable 1 Loans individually evaluated for impairment $ — $ 15,164 $ 9,824 $ — $ 24,988 Loans collectively evaluated for impairment 25,425 111,288 88,228 9,354 234,295 Total loans receivable $ 25,425 $ 126,452 $ 98,052 $ 9,354 $ 259,283 December 31, 2014 Construction Owner Commercial Commercial Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 1,051 $ 676 $ — $ 1,727 Loans collectively evaluated for impairment 586 1,240 693 161 2,680 Total allowance for loan losses $ 586 $ 2,291 $ 1,369 $ 161 $ 4,407 Loans Receivable 1 Loans individually evaluated for impairment $ — $ 15,018 $ 9,984 $ — $ 25,002 Loans collectively evaluated for impairment 9,526 96,602 71,073 1,248 178,449 Total loans receivable $ 9,526 $ 111,620 $ 81,057 $ 1,248 $ 203,451 1 Loans receivable includes $21.8 million of U.S. government guaranteed loans as of September 30, 2015, of which $19.5 million are included in loans individually evaluated for impairment and $2.3 million are included in loans collectively evaluated for impairment, as presented above. As of December 31, 2014, loans receivable includes $21.3 million of U.S. government guaranteed loans, of which $19.5 million are included in loans individually evaluated for impairment and $2.0 million are included in loans collectively evaluated for impairment, as presented above. Loans individually evaluated for impairment as of the dates presented are summarized in the following tables. September 30, 2015 Recorded Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 4,155 $ 3,290 $ 865 Independent Pharmacies 2,279 1,679 600 Veterinary Industry 3,390 2,979 411 Total 9,824 7,948 1,876 Owner Occupied Commercial Real Estate Death Care Management 1,477 1,309 168 Healthcare 2,498 1,990 508 Veterinary Industry 11,189 8,252 2,937 Total 15,164 11,551 3,613 Total $ 24,988 $ 19,499 $ 5,489 December 31, 2014 Recorded Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 4,205 $ 3,540 $ 665 Independent Pharmacies 2,199 1,492 707 Veterinary Industry 3,580 3,113 467 Total 9,984 8,145 1,839 Owner Occupied Commercial Real Estate Death Care Management 1,720 1,505 215 Healthcare 2,309 1,919 390 Veterinary Industry 10,715 7,456 3,259 Other Industries 274 274 — Total 15,018 11,154 3,864 Total $ 25,002 $ 19,299 $ 5,703 The following table presents evaluated balances of loans classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan fees or costs. September 30, 2015 Recorded Investment With a With No Total Unpaid Related Commercial & Industrial Healthcare $ 4,152 $ 3 $ 4,155 $ 4,324 $ 483 Independent Pharmacies 2,091 188 2,279 2,668 335 Veterinary Industry 3,352 38 3,390 4,069 106 Total Commercial & Industrial 9,595 229 9,824 11,061 924 Owner Occupied Commercial Real Estate Death Care Management 1,477 — 1,477 1,613 11 Healthcare 2,361 137 2,498 2,606 65 Veterinary Industry 10,743 446 11,189 12,042 956 Total Owner Occupied Commercial Real Estate 14,581 583 15,164 16,261 1,032 Total Impaired Loans $ 24,176 $ 812 $ 24,988 $ 27,322 $ 1,956 December 31, 2014 Recorded Investment With a With No Total Unpaid Related Commercial & Industrial Healthcare $ 4,202 $ 3 $ 4,205 $ 4,854 $ 361 Independent Pharmacies 2,005 194 2,199 2,497 206 Veterinary Industry 3,540 40 3,580 4,062 109 Total Commercial & Industrial 9,747 237 9,984 11,413 676 Owner Occupied Commercial Real Estate Death Care Management 1,720 — 1,720 1,856 20 Healthcare 2,268 41 2,309 2,413 82 Veterinary Industry 9,796 919 10,715 11,571 947 Other Industries 274 — 274 367 2 Total Owner Occupied Commercial Real Estate 14,058 960 15,018 16,207 1,051 Total Impaired Loans $ 23,805 $ 1,197 $ 25,002 $ 27,620 $ 1,727 Three months ended Three months ended Average Interest Average Interest Commercial & Industrial Healthcare $ 3,460 $ 24 $ 2,783 $ — Independent Pharmacies 2,395 13 818 5 Veterinary Industry 3,790 5 2,910 36 Total Commercial & Industrial 9,645 42 6,511 41 Owner Occupied Commercial Real Estate Death Care Management 1,412 — — — Healthcare 2,474 — 2,426 — Veterinary Industry 11,412 42 10,217 81 Total Owner Occupied Commercial Real Estate 15,298 42 12,643 81 Total $ 24,943 $ 84 $ 19,154 $ 122 Nine months ended Nine months ended Average Interest Average Interest Commercial & Industrial Healthcare $ 3,388 $ 72 $ 2,051 $ 1 Independent Pharmacies 2,524 38 361 8 Veterinary Industry 3,482 13 3,714 63 Total Commercial & Industrial 9,394 123 6,126 72 Owner Occupied Commercial Real Estate Death Care Management 1,461 — — — Healthcare 2,372 — 2,047 — Veterinary Industry 11,357 132 10,971 252 Total Owner Occupied Commercial Real Estate 15,190 132 13,018 252 Total $ 24,584 $ 255 $ 19,144 $ 324 The following table represent the types of TDRs that were made during the periods presented: Three months ended September 30, 2015 Three months ended September 30, 2014 All Restructurings All Restructurings Number of Pre- Post- Number of Pre- Post- Interest Only Commercial & Industrial Independent Pharmacies — $ — $ — 1 $ 144 $ 143 Total Interest Only — — — 1 144 143 Extended Amortization Commercial & Industrial Independent Pharmacies 2 322 313 — — — Total Extended Amortization 2 322 313 — — — Payment Deferral Owner Occupied Commercial Real Estate Deathcare Management — — — 1 353 217 Total Payment Deferral — — — 1 353 217 Total 2 $ 322 $ 313 2 $ 497 $ 360 Nine months ended September 30, 2015 Nine months ended September 30, 2014 All Restructurings All Restructurings Number of Pre- modification Recorded Post- Number of Pre- Post- Interest Only Commercial & Industrial Healthcare 3 $ 1,093 $ 1,093 — $ — $ — Independent Pharmacies — — — 1 144 143 Owner Occupied Commercial Real Estate Healthcare 1 95 95 — — — Veterinary Industry — — — 1 8 8 Total Interest Only 4 1,188 1,188 2 152 151 Extended Amortization Commercial & Industrial Independent Pharmacies 2 322 313 2 379 367 Total Extended Amortization 2 322 313 2 379 367 Payment Deferral Commercial & Industrial Veterinary Industry — — — 3 219 216 Owner Occupied Commercial Real Estate Deathcare Management — — — 1 353 217 Total Payment Deferral — — — 4 572 433 Total 6 $ 1,510 $ 1,501 8 $ 1,103 $ 951 Concessions made to improve a loan’s performance have varying degrees of success. No TDRs that were modified within the twelve months ended September 30, 2015 subsequently defaulted during the three and nine months ended September 30, 2015. During the three and nine months ended September 30, 2014, one TDR that was modified within the twelve months ended September 30, 2014 subsequently defaulted. This TDR was an owner occupied commercial real estate deathcare management loan that was previously modified for payment deferral. The recorded investment for this TDR at September 30, 2014 was $217 thousand.

Servicing Assets

Servicing Assets	9 Months Ended
	Sep. 30, 2015
Transfers and Servicing [Abstract]
Servicing Assets	Note 6. Servicing Assets Loans serviced for others are not included in the accompanying balance sheet. The unpaid principal balances of loans serviced for others were $1.79 billion and $1.47 billion at September 30, 2015 and December 31, 2014, respectively. The following summarizes the activity pertaining to servicing rights: Three Months Ended Nine Months Ended 2015 2014 2015 2014 Balance at beginning of period $ 39,983 $ 33,181 $ 34,999 $ 29,053 Additions, net 3,613 2,902 10,322 7,653 Changes in fair value (3,006 ) (984 ) (4,731 ) (1,607 ) Balance at end of period $ 40,590 $ 35,099 $ 40,590 $ 35,099 The fair value of servicing rights was determined using discount rates ranging from 9.23% to 13.52% on September 30, 2015, and 6.45% to 12.52% on September 30, 2014. The fair value of servicing rights was determined using prepayment speeds ranging from 4.05% to 9.90% on September 30, 2015 and 1.89% to 9.24% on September 30, 2014, depending on the stratification of the specific right. Changes to fair value are reported in loan servicing revenue and revaluation. The fair value of servicing rights is highly sensitive to changes in underlying assumptions. Changes in prepayment speed assumptions have the most significant impact on the fair value of servicing rights. Generally, as interest rates rise on variable rate loans, loan prepayments increase due to an increase in refinance activity, which results in a decrease in the fair value of servicing assets. Measurement of fair value is limited to the conditions existing and the assumptions used as of a particular point in time, and those assumptions may not be appropriate if they are applied at a different time. Live Oak Bancshares, Inc. Notes to Unaudited Consolidated Financial Statements

Borrowings

Borrowings	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Borrowings	Note 7. Borrowings Total outstanding short and long term borrowings consisted of the following: September 30, December 31, Short term borrowings On September 18, 2014, the Company entered into a line of credit of $6.1 million with an unaffiliated commercial bank, secured by 1,900,000 shares of common stock of nCino, Inc., a former subsidiary of the Company. At December 31, 2014 there was $6.1 million advanced on the line of credit. Interest accrues at 30 day LIBOR (0.16% at December 31, 2014) plus 3.50% for a term of 12 months. Payments are interest only with all principal and accrued interest due on September 18, 2015. This loan was repaid in full on February 23, 2015. $ — $ 6,100 Total short term borrowings $ — $ 6,100 Long term borrowings In April 2011, the Company elected to participate in the U.S. Treasury’s Small Business Lending Fund program (“SBLF”) whereby the U.S. Treasury agreed to purchase $6.8 million in senior securities. During the initial interest period the applicable interest rate was set at 1.5%. For all remaining interest periods, which commenced on January 1, 2012, the interest rate is determined based on a formula which encompasses the percentage change in qualified lending as well as a non-qualifying portion percentage. This rate can range from 1.5% to 10.8%. At September 30, 2015 the interest rate was 1.50%. Interest is payable quarterly in arrears. With the approval of the Company’s regulator, the Company may exit the Small Business Lending Fund at any time simply by repaying the funding provided along with any accrued but unpaid interest. If the institution wishes to repay its SBLF funding in partial payments, each partial payment must be at least 25% of the original funding amount. All senior securities will mature on September 13, 2021 at which time all principal and accrued interest will be due. $ 6,800 $ 6,800 On May 12, 2014, Independence Aviation financed the purchase of an airplane by entering into a promissory note with an unaffiliated commercial bank in the amount of $6 million which carries a fixed rate of 4.97% for a term of 59 months. Monthly payments are set at $48 thousand with all principal and accrued interest due on May 12, 2019. 5,631 5,842 On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus for a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments are interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments beginning in October 2016 will be $146 thousand with all principal and accrued interest due on September 11, 2021. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. The construction line is fully disbursed and there was no remaining available credit on this construction line at September 30, 2015. 24,000 16,914 On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank, with the first advance of $5 million on December 14, 2014. The note is unsecured and accrues interest at LIBOR plus 3.50% for a term of 36 months. The current rate is 3.693%. Payments are interest only with all principal and accrued interest due on September 18, 2017. There is no outstanding balance at September 30, 2015; therefore, there is $8.1 million of available credit on this note at September 30, 2015. — 5,000 On August 1, 2014, the Company entered into a note payable line of credit of $15 million with an unaffiliated commercial bank, secured by 100% of Live Oak Banking Company’s outstanding common stock. Interest accrues at LIBOR plus 4.00% for a term of 36 months. Payments are interest only with all principal and accrued interest due on August 1, 2017. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. This note was repaid in full on July 29, 2015. — 7,210 On March 10, 2015, Independence Aviation refinanced an existing loan with Live Oak Banking Company and entered into a new loan with an unaffiliated commercial bank in the amount of $1.2 million which carries a fixed rate of 4.96% for a term of 51 months. Monthly payments are set at $9 thousand with all principal and accrued interest due on June 10, 2019. 1,173 — On February 23, 2015 the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at September 30, 2015 is 4.25%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $4.5 million at September 30, 2015. Underlying loans carry a risk grade of 3 and are current with no delinquencies. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. 4,475 — With the acquisition of GLS on September 1, 2013, the Company assumed the obligation to pay a former GLS partner $250 thousand at $10 thousand a month over a 24 month period. This obligation was paid in full on August 17, 2015. — 83 Total long term borrowings $ 42,079 $ 41,849 Live Oak Bancshares, Inc. Notes to Unaudited Consolidated Financial Statements

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2015
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Note 8. Fair Value of Financial Instruments Fair Value Hierarchy There are three levels of inputs in the fair value hierarchy that may be used to measure fair value. Financial instruments are considered Level 1 Level 2 Level 3 Financial Instruments Measured at Fair Value The following sections provide a description of the valuation methodologies used for instruments measured at fair value, as well as the general classification of such instruments pursuant to the fair value hierarchy: Investment Securities The Company invested $1.9 million in the 504 Fund mutual fund on March 31, 2015 and accordingly identified it as a Level 1 investment on that date. During the second quarter of 2015, the Company transferred this $1.9 million investment from Level 1 to Level 2, where it continues to be classified. Impaired Loans Servicing Assets: Foreclosed Assets: Recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis. September 30, 2015 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 27,213 $ — $ 27,213 $ — Residential mortgage-backed securities 22,466 — 22,466 — Mutual fund 1,949 — 1,949 — Servicing assets 1 40,590 — — 40,590 Total assets at fair value $ 92,218 $ — $ 51,628 $ 40,590 December 31, 2014 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 35,309 $ — $ 35,309 $ — Residential mortgage-backed securities 14,009 — 14,009 — Servicing assets 1 34,999 — — 34,999 Total assets at fair value $ 84,317 $ — $ 49,318 $ 34,999 1 See Note 6 for a rollforward of recurring Level 3 fair values for servicing assets. Non-recurring Fair Value The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis. September 30, 2015 Total Level 1 Level 2 Level 3 Impaired loans $ 22,224 $ — $ — $ 22,224 Foreclosed assets 48 — — 48 Total assets at fair value $ 22,272 $ — $ — $ 22,272 December 31, 2014 Total Level 1 Level 2 Level 3 Impaired loans $ 24,016 $ — $ — $ 24,016 Foreclosed assets 371 — — 371 Total assets at fair value $ 24,387 $ — $ — $ 24,387 Level 3 Analysis For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of September 30, 2015 and December 31, 2014 the significant unobservable inputs used in the fair value measurements were as follows: September 30, 2015 Level 3 Assets with Significant Fair Value Valuation Technique Significant Range Impaired Loans $ 22,224 Discounted appraisals Appraisal adjustments (1) 10% to 20% Foreclosed Assets $ 48 Discounted appraisals Appraisal adjustments (1) 10% to 20% December 31, 2014 Level 3 Assets with Significant Fair Value Valuation Technique Significant Range Impaired Loans $ 24,016 Discounted appraisals Appraisal adjustments (1) 10% to 20% Foreclosed Assets $ 371 Discounted appraisals Appraisal adjustments (1) 10% to 20% (1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments. Estimated Fair Value of Other Financial Instruments GAAP also requires disclosure of fair value information about financial instruments carried at book value on the balance sheet. In cases where quoted market prices are not available, fair values are based on estimates using present value or other valuation techniques. Those techniques are significantly affected by the assumptions used, including the discount rate and estimates of future cash flows. In that regard, the derived fair value estimates cannot be substantiated by comparison to independent markets and, in many cases, could not be realized in immediate settlement of the instruments. Accordingly, the aggregate fair value amounts presented do not represent the underlying value of the Company. The following methods and assumptions were used by the Company in estimating its fair value disclosures for financial instruments not measured at fair value on the balance sheets: Cash and due from banks Certificates of deposit with other banks Loans held for sale: Loans Accrued Interest: Deposits Short and long term borrowings: The carrying amounts and estimated fair values of the Company’s financial instruments are as follows: September 30, 2015 Carrying Quoted Price Significant Significant Total Fair Value Financial assets Cash and due from banks $ 129,881 $ 129,881 $ — $ — $ 129,881 Certificates of deposit with other banks 10,000 9,984 — — 9,984 Investment securities, available-for-sale 51,628 — 51,628 — 51,628 Loans held for sale 443,871 — — 458,780 458,780 Loans, net of allowance for loan losses 253,399 — — 247,906 247,906 Servicing assets 40,590 — — 40,590 40,590 Accrued interest receivable 4,841 4,841 — — 4,841 Financial liabilities Deposits 762,628 — 754,715 — 754,715 Accrued interest payable 243 243 — — 243 Long term borrowings 42,079 — — 44,987 44,987 December 31, 2014 Carrying Quoted Price Significant Significant Total Fair Value Financial assets Cash and due from banks $ 29,902 $ 29,902 $ — $ — $ 29,902 Certificates of deposit with other banks 10,000 9,861 — — 9,861 Investment securities, available-for-sale 49,318 — 49,318 — 49,318 Loans held for sale 295,180 — — 304,504 304,504 Loans, net of allowance for loan losses 199,529 — — 194,007 194,007 Servicing assets 34,999 — — 34,999 34,999 Accrued interest receivable 3,059 3,059 — — 3,059 Financial liabilities Deposits 522,080 — 522,058 — 522,058 Accrued interest payable 190 190 — — 190 Short term borrowings 6,100 — — 6,100 6,100 Long term borrowings 41,849 — — 44,738 44,738

Commitments and Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 9. Commitments and Contingencies Litigation In the normal course of business the Company is involved in various legal proceedings. Management believes that the outcome of such proceedings will not materially affect the financial position, results of operations or cash flows of the Company. Financial Instruments with Off-balance-sheet Risk The Company is party to financial instruments with off-balance-sheet risk in the normal course of business to meet the financing needs of its customers. These financial instruments include commitments to extend credit and standby letters of credit. These instruments involve, to varying degrees, credit risk in excess of the amount recognized in the balance sheet. The Company’s exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit and standby letters of credit is represented by the contractual amount of those instruments. The Company uses the same credit policies in making commitments and conditional obligations as for on-balance-sheet instruments. A summary of the Company’s commitments is as follows: September 30, December 31, Commitments to extend credit $ 747,909 $ 537,951 Plexus Capital - Fund II Investment Commitment 100 100 Plexus Capital - Fund III Investment Commitment 300 350 Total unfunded off-balance sheet credit risk $ 748,309 $ 538,401 Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements. The Company evaluates each customer’s creditworthiness on a case-by-case basis. The amount of collateral obtained, if deemed necessary by the Company upon extension of credit, is based on management’s credit evaluation of the party. Collateral held varies, but may include accounts receivable, inventory, property and equipment, residential real estate and income-producing commercial properties. In 2012, the Company began issuing commitment letters after approval of the loan by the Credit Department. Commitment letters generally expire ninety days after issuance. Standby letters of credit are conditional commitments issued by the Company to guarantee the performance of a customer to a third party. Those guarantees are primarily issued to support public and private borrowing arrangements. The credit risk involved in issuing letters of credit is essentially the same as that involved in extending loan facilities to customers. Collateral held varies as specified above and is required in instances which the Company deems necessary. There were no standby letters of credit for the periods presented. Concentrations of Credit Risk Although the Company is not subject to any geographic concentrations, a substantial amount of the Company’s loans and commitments to extend credit have been granted to customers in the independent pharmacy and veterinary verticals. The concentrations of credit by type of loan are set forth in Note 5. The distribution of commitments to extend credit approximates the distribution of loans outstanding. The Company does not have a significant number of credits to any single borrower or group of related borrowers whereby their retained exposure exceeds $2.0 million, except for one relationship that has a retained exposure of $2.8 million. The Company from time-to-time may have cash and cash equivalents on deposit with financial institutions that exceed federally-insured limits.

Stock Plans

Stock Plans	9 Months Ended
	Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Plans	Note 10. Stock Plans On March 20, 2015, the Company adopted the 2015 Omnibus Stock Incentive Plan which replaced the previously existing Amended Incentive Stock Option Plan and Nonstatutory Stock Option Plan. The 2015 Omnibus Plan authorized awards covering a maximum of 4,300,000 common voting shares and has an expiration date of March 20, 2025. Options or restricted shares granted under this plan expire no more than 10 years from date of grant. Exercise prices under the plan are set by the Board of Directors at the date of grant, but shall not be less than 100% of fair market value of the related stock at the date of the grant. Options or restricted shares vest over a minimum of three years from the date of the grant. Stock Options Compensation cost relating to share-based payment transactions are recognized in the financial statements with measurement based upon the fair value of the equity or liability instruments issued. For the three months ended September 30, 2015 and 2014, the Company recognized $431 thousand and $33 thousand in compensation expense for stock options, respectively. For the nine months ended September 30, 2015 and 2014, the Company recognized $726 thousand and $112 thousand in compensation expense for stock options, respectively. Stock option activity under the plan during the nine month periods ended September 30, 2015 and 2014 is summarized below. Shares Weighted Weighted Aggregate Outstanding at December 31, 2014 1,737,570 $ 5.51 Exercised 47,570 4.52 Forfeited 192,671 8.38 Granted 1,829,748 15.52 Outstanding at September 30, 2015 3,327,077 $ 10.86 9.16 years $ 29,197,309 Exercisable at September 30, 2015 158,950 $ 4.65 8.05 years $ 2,382,744 Shares Weighted Weighted Aggregate Outstanding at December 31, 2013 225,000 $ 1.01 Exercised 191,660 0.92 Forfeited 170,590 4.40 Granted 1,874,820 5.48 Outstanding at September 30, 2014 1,737,570 $ 5.51 9.54 years $ 8,902,969 Exercisable at September 30, 2014 22,227 $ 1.52 7.04 years $ 202,486 The following is a summary of non-vested stock option activity for the Company for the nine months ended September 30, 2015 and 2014. Shares Weighted Non-vested at December 31, 2014 1,704,230 $ 1.18 Granted 1,829,748 6.79 Vested 173,180 0.97 Forfeited 192,671 2.63 Non-vested at September 30, 2015 3,168,127 $ 4.35 Shares Weighted Non-vested at December 31, 2013 91,754 $ 0.44 Granted 1,874,820 1.13 Vested 80,641 0.44 Forfeited 170,590 0.58 Non-vested at September 30, 2014 1,715,343 $ 1.18 The total intrinsic value of options exercised at September 30, 2015 and 2014 was $392 thousand and $771 thousand, respectively. At September 30, 2015, unrecognized compensation costs relating to stock options amounted to $13.1 million which will be expensed over the next 7 years. The weighted average fair value of each stock option grant is estimated on the date of grant using the Black-Scholes option-pricing model. The expected volatility is based on historical volatility. The risk-free interest rates for periods within the contractual life of the awards are based on the U.S. Treasury yield curve in effect at the time of the grant. The expected life is based on historical exercise experience. The dividend yield assumption is based on the Company’s history and expectation of dividend payouts. Weighted average assumptions used for options granted during 2015 were as follows: risk free rate of 1.96%, dividend yield of 1.00%, volatility of 43.38% and average life of 4-7 years. Restricted Stock Restricted stock activity under the plan during the first nine months of 2015 is summarized below. Shares Weighted Outstanding at December 31, 2014 — $ — Granted 65,122 16.10 Vested — — Exercised — — Forfeited 607 10.63 Non-vested at September 30, 2015 64,515 $ 16.15 For the three months ended September 30, 2015 and 2014, the Company recognized $67 thousand and a credit of ($19) thousand in compensation expense due to forfeited shares for restricted stock, respectively. For the nine months ended September 30, 2015 and 2014, the Company recognized $83 thousand and $143 thousand in compensation expense for restricted stock, respectively. At September 30, 2015, unrecognized compensation costs relating to restricted stock amounted to $959 thousand which will be expensed over the next 3.75 years. The fair value of each restricted stock unit is based on the market value of the Company’s stock on the date of the grant.

Earnings Per Share (Tables)

Earnings Per Share (Tables)	9 Months Ended
	Sep. 30, 2015
Schedule of Basic and Diluted Earnings Per Share	Basic and diluted earnings per share are computed based on the weighted average number of shares outstanding during each period. Diluted earnings per share reflects the potential dilution that could occur, upon the exercise of stock options or upon the vesting of restricted stock grants, any of which would result in the issuance of common stock that would then be shared in the net income of the Company. Three Months Ended Nine Months Ended 2015 2014 2015 2014 Basic earnings per share: Net income available to common shareholders $ 2,901 $ 641 $ 14,910 $ 7,600 Weighted-average basic shares outstanding 32,824,587 25,632,505 30,037,436 22,412,646 Basic earnings per share $ 0.09 $ 0.03 $ 0.50 $ 0.34 Diluted earnings per share: Net income available to common shareholders, for diluted earnings per share $ 2,901 $ 641 $ 14,910 $ 7,600 Total weighted-average basic shares outstanding 32,824,587 25,632,505 30,037,436 22,412,646 Add effect of dilutive stock options and restricted stock grants 1,092,695 603,195 892,794 286,789 Total weighted-average diluted shares outstanding 33,917,282 26,235,700 30,930,230 22,699,435 Diluted earnings per share $ 0.09 $ 0.02 $ 0.48 $ 0.33 Anti-dilutive shares 1,391,828 328,210 1,562,168 328,210
Pro Forma [Member]
Schedule of Basic and Diluted Earnings Per Share	Pro forma earnings per share Because the Company was not a taxable entity prior to August 3, 2014, pro forma amounts for income tax expense and basic and diluted earnings per share have been presented below assuming the Company’s effective tax rate of 38.5% for the three and nine months ended September 30, 2014. Three Months Ended Nine Months Ended Pro forma net income available to common shareholders, after tax $ 4,071 $ 8,349 Pro forma basic earnings per share $ 0.16 $ 0.37 Pro forma diluted earnings per share $ 0.16 $ 0.37

Securities (Tables)

Securities (Tables)	9 Months Ended
	Sep. 30, 2015
Investments, Debt and Equity Securities [Abstract]
Summary of Carrying Amount and Fair Value of Securities	The carrying amount of securities and their approximate fair values are reflected in the following table: Amortized Unrealized Unrealized Fair September 30, 2015 US government agencies $ 26,987 $ 226 $ — $ 27,213 Residential mortgage-backed securities 22,570 32 136 22,466 Mutual fund 1,930 19 — 1,949 $ 51,487 $ 277 $ 136 $ 51,628 December 31, 2014 US government agencies $ 35,207 $ 127 $ 25 $ 35,309 Residential mortgage-backed securities 13,973 92 56 14,009 $ 49,180 $ 219 $ 81 $ 49,318
Summary of Gross Unrealized Losses and Fair Value	The following tables show gross unrealized losses and fair value, aggregated by investment category and length of time that the individual securities have been in a continuous unrealized loss position. Less Than 12 Months 12 Months or More Total September 30, 2015 Fair Unrealized Fair Unrealized Fair Unrealized Residential mortgage-backed securities $ 14,453 $ 114 $ 3,269 $ 22 $ 17,722 $ 136 Total $ 14,453 $ 114 $ 3,269 $ 22 $ 17,722 $ 136 Less Than 12 Months 12 Months or More Total December 31, 2014 Fair Unrealized Fair Unrealized Fair Unrealized US government agencies $ — $ — $ 1,224 $ 25 $ 1,224 $ 25 Residential mortgage-backed securities 2,234 4 5,158 52 7,392 56 Total $ 2,234 $ 4 $ 6,382 $ 77 $ 8,616 $ 81
Summary of Investment Securities by Maturity	The following is a summary of investment securities by maturity: September 30, 2015 Available-for-sale Amortized Fair One to five years $ 26,987 $ 27,213 Five to ten years 10,052 10,057 After 10 years 12,518 12,409 $ 49,557 $ 49,679

Loans and Allowance for Loan 20

Loans and Allowance for Loan Losses (Tables)	9 Months Ended
	Sep. 30, 2015
Receivables [Abstract]
Summary of Loans	Loans consist of the following: September 30, December 31, Commercial & Industrial Agriculture $ 30 $ — Death Care Management 4,831 3,603 Healthcare 13,563 12,319 Independent Pharmacies 41,123 34,079 Registered Investment Advisors 16,304 9,660 Veterinary Industry 20,985 20,902 Other Industries 1,216 494 Total 98,052 81,057 Construction & Development Agriculture 12,233 3,910 Death Care Management 991 92 Healthcare 7,722 2,957 Independent Pharmacies 687 215 Registered Investment Advisors 75 — Veterinary Industry 3,038 2,207 Other Industries 679 145 Total 25,425 9,526 Owner Occupied Commercial Real Estate Agriculture 125 259 Death Care Management 19,575 18,879 Healthcare 33,342 26,173 Independent Pharmacies 5,752 4,750 Registered Investment Advisors 2,981 2,161 Veterinary Industry 61,092 57,934 Other Industries 3,585 1,464 Total 126,452 111,620 Commercial Land Agriculture 9,354 1,248 Total 9,354 1,248 Total Loans 1 259,283 203,451 Net Deferred Costs 2,685 2,060 Discount on SBA 7(a) Unguaranteed 2 (2,416 ) (1,575 ) Loans, Net of Unearned $ 259,552 $ 203,936 1 Total loans include $21.8 million and $21.3 million of U.S. government guaranteed loans as of September 30, 2015 and December 31, 2014, respectively. 2 The Company measures the carrying value of the retained portion of loans sold at fair value under ASC Subtopic 825-10. The value of these retained loan balances is discounted based on the estimates derived from comparable unguaranteed loan sales.
Summary of Risk Grades of Each Category of Loans	The following tables summarize the risk grades of each category: Risk Grades Risk Grade Risk Grades Total 1 September 30, 2015 Commercial & Industrial Agriculture $ 30 $ — $ — $ 30 Death Care Management 4,727 104 — 4,831 Healthcare 8,007 556 5,000 13,563 Independent Pharmacies 34,795 2,173 4,155 41,123 Registered Investment Advisors 15,952 352 — 16,304 Veterinary Industry 15,873 566 4,546 20,985 Other Industries 1,070 146 — 1,216 Total 80,454 3,897 13,701 98,052 Construction & Development Agriculture 12,141 92 — 12,233 Death Care Management 991 — — 991 Healthcare 7,722 — — 7,722 Independent Pharmacies 687 — — 687 Registered Investment Advisors 75 — — 75 Veterinary Industry 3,038 — — 3,038 Other Industries 679 — — 679 Total 25,333 92 — 25,425 Owner Occupied Commercial Real Estate Agriculture 125 — — 125 Death Care Management 17,041 832 1,702 19,575 Healthcare 28,804 1,716 2,822 33,342 Independent Pharmacies 5,355 397 — 5,752 Registered Investment Advisors 2,981 — — 2,981 Veterinary Industry 43,754 2,690 14,648 61,092 Other Industries 3,585 — — 3,585 Total 101,645 5,635 19,172 126,452 Commercial Land Agriculture 9,354 — — 9,354 Total 9,354 — — 9,354 Total $ 216,786 $ 9,624 $ 32,873 $ 259,283 Risk Grades Risk Grade Risk Grades Total 1 December 31, 2014 Commercial & Industrial Death Care Management $ 3,603 $ — $ — $ 3,603 Healthcare 6,995 538 4,786 12,319 Independent Pharmacies 27,673 2,726 3,680 34,079 Registered Investment Advisors 9,660 — — 9,660 Veterinary Industry 15,513 1,121 4,268 20,902 Other Industries 333 161 — 494 Total 63,777 4,546 12,734 81,057 Construction & Development Agriculture 3,910 — — 3,910 Death Care Management 92 — — 92 Healthcare 2,957 — — 2,957 Independent Pharmacies 215 — — 215 Veterinary Industry 2,207 — — 2,207 Other Industries 145 — — 145 Total 9,526 — — 9,526 Owner Occupied Commercial Real Estate Agriculture 259 — — 259 Death Care Management 16,519 639 1,721 18,879 Healthcare 22,778 938 2,457 26,173 Independent Pharmacies 4,709 41 — 4,750 Registered Investment Advisors 2,161 — — 2,161 Veterinary Industry 40,281 3,601 14,052 57,934 Other Industries 1,176 — 288 1,464 Total 87,883 5,219 18,518 111,620 Commercial Land Agriculture 1,248 — — 1,248 Total 1,248 — — 1,248 Total $ 162,434 $ 9,765 $ 31,252 $ 203,451 1 Total loans include $21.8 million of U.S. government guaranteed loans as of September 30, 2015, segregated by risk grade as follows: Risk Grades 1 – 4 = $0, Risk Grade 5 = $1.1 million, Risk Grades 6 – 8 = $20.7 million. As of December 31, 2014 total loans include $21.3 million of U.S. government guaranteed loans, segregated by risk grade as follows: Risk Grades 1 – 4 = $0, Risk Grade 5 = $1.1 million, Risk Grades 6 – 8 = $20.2 million.
Summary of Age Analysis of Past Due Loans	The following tables show an age analysis of past due loans as of the dates presented. Less Than 30 30-89 Days 30-89 Days Greater Total Not Current Total Loans Loans 90 September 30, 2015 Commercial & Industrial Agriculture $ — $ — $ — $ — $ — $ 30 $ 30 $ — Death Care Management — — — — — 4,831 4,831 — Healthcare — 277 — 2,321 2,598 10,965 13,563 — Independent Pharmacies 313 615 — 1,170 2,098 39,025 41,123 — Registered Investment Advisors — — — — — 16,304 16,304 — Veterinary Industry 114 110 646 2,257 3,127 17,858 20,985 — Other Industries — — — — — 1,216 1,216 — Total 427 1,002 646 5,748 7,823 90,229 98,052 — Construction & Development Agriculture — — — — — 12,233 12,233 — Death Care Management — — — — — 991 991 — Healthcare — 46 — — 46 7,676 7,722 — Independent Pharmacies — — — — — 687 687 — Registered Investment Advisors — — — — — 75 75 — Veterinary Industry — — — — — 3,038 3,038 — Other Industries — — — — — 679 679 — Total — 46 — — 46 25,379 25,425 — Owner Occupied Commercial Real Estate Agriculture — — — — — 125 125 — Death Care Management 1,479 — — — 1,479 18,096 19,575 — Healthcare — — — 2,308 2,308 31,034 33,342 — Independent Pharmacies — — — — — 5,752 5,752 — Registered Investment Advisors — — — — — 2,981 2,981 — Veterinary Industry 2,959 5,279 165 4,651 13,054 48,038 61,092 — Other Industries — — — — — 3,585 3,585 — Total 4,438 5,279 165 6,959 16,841 109,611 126,452 — Commercial Land Agriculture — — — — — 9,354 9,354 — Total — — — — — 9,354 9,354 — Total 1 $ 4,865 $ 6,327 $ 811 $ 12,707 $ 24,710 $ 234,573 $ 259,283 $ — Less Than 30 30-89 Days 30-89 Days Greater Total Not Current Total Loans Loans 90 December 31, 2014 Commercial & Industrial Death Care Management $ — $ — $ — $ — $ — $ 3,603 $ 3,603 $ — Healthcare — 1,059 232 2,420 3,711 8,608 12,319 — Independent Pharmacies — 98 — 1,224 1,322 32,757 34,079 — Registered Investment Advisors — — — — — 9,660 9,660 — Veterinary Industry 1,025 276 4 2,228 3,533 17,369 20,902 — Other Industries — — — — — 494 494 — Total 1,025 1,433 236 5,872 8,566 72,491 81,057 — Construction & Development Agriculture — — — — — 3,910 3,910 — Death Care Management — — — — — 92 92 — Healthcare — — — — — 2,957 2,957 — Independent Pharmacies — — — — — 215 215 — Veterinary Industry — — — — — 2,207 2,207 — Other Industries — — — — — 145 145 — Total — — — — — 9,526 9,526 — Owner Occupied Commercial Real Estate Agriculture — — — — — 259 259 — Death Care Management — — — 1,721 1,721 17,158 18,879 — Healthcare — 145 230 2,082 2,457 23,716 26,173 — Independent Pharmacies — — — — — 4,750 4,750 — Registered Investment Advisors — — — — — 2,161 2,161 — Veterinary Industry 2,464 5,101 1,951 2,836 12,352 45,582 57,934 — Other Industries — — — 275 275 1,189 1,464 — Total 2,464 5,246 2,181 6,914 16,805 94,815 111,620 — Commercial Land Agriculture — — — — — 1,248 1,248 — Total — — — — — 1,248 1,248 — Total 1 $ 3,489 $ 6,679 $ 2,417 $ 12,786 $ 25,371 $ 178,080 $ 203,451 $ — 1 Total loans include $21.8 million of U.S. government guaranteed loans as of September 30, 2015, of which $11.1 million is greater than 90 days past due, $3.1 million is 30-89 days past due and $7.6 million is included in current loans as presented above. As of December 31, 2014, total loans include $21.3 million of U.S. government guaranteed loans, of which $11.7 million is greater than 90 days past due, $3.5 million is 30-89 days past due and $6.1 million is included in current loans as presented above.
Schedule of Nonaccrual Loans	Nonaccrual loans as of September 30, 2015 and December 31, 2014 are as follows: September 30, 2015 Loan Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 2,321 $ 2,136 $ 185 Independent Pharmacies 1,483 1,344 139 Veterinary Industry 3,017 2,979 38 Total 6,821 6,459 362 Owner Occupied Commercial Real Estate Death Care Management 1,479 1,309 170 Healthcare 2,308 1,990 318 Veterinary Industry 7,775 6,063 1,712 Total 11,562 9,362 2,200 Total $ 18,383 $ 15,821 $ 2,562 December 31, 2014 Loan Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 2,652 $ 2,368 $ 284 Independent Pharmacies 1,224 1,139 85 Veterinary Industry 3,257 3,113 144 Total 7,133 6,620 513 Owner Occupied Commercial Real Estate Death Care Management 1,721 1,505 216 Healthcare 2,312 1,919 393 Veterinary Industry 7,251 5,236 2,015 Other Industries 275 275 — Total 11,559 8,935 2,624 Total $ 18,692 $ 15,555 $ 3,137
Schedule of Allowance for Loan Losses by Portfolio Segment Allowance	The following tables detail activity in the allowance for loan losses by portfolio segment allowance for the periods presented: Three months ended: Construction & Owner Commercial Commercial Total September 30, 2015 Beginning Balance $ 844 $ 2,346 $ 1,653 $ 340 $ 5,183 Charge offs — (7 ) (280 ) — (287 ) Recoveries — 12 33 — 45 Provision 336 (260 ) 830 306 1,212 Ending Balance $ 1,180 $ 2,091 $ 2,236 $ 646 $ 6,153 September 30, 2014 Beginning Balance $ 300 $ 1,931 $ 1,312 $ 25 $ 3,568 Charge offs — (227 ) (294 ) — (521 ) Recoveries — 5 13 — 18 Provision 159 316 (24 ) 61 512 Ending Balance $ 459 $ 2,025 $ 1,007 $ 86 $ 3,577 Nine months ended: Construction & Owner Commercial Commercial Total September 30, 2015 Beginning Balance $ 586 $ 2,291 $ 1,369 $ 161 $ 4,407 Charge offs — (128 ) (638 ) — (766 ) Recoveries — 100 73 — 173 Provision 594 (172 ) 1,432 485 2,339 Ending Balance $ 1,180 $ 2,091 $ 2,236 $ 646 $ 6,153 September 30, 2014 Beginning Balance $ 350 $ 1,511 $ 862 $ — $ 2,723 Charge offs — (346 ) (302 ) — (648 ) Recoveries — 72 19 — 91 Provision 109 788 428 86 1,411 Ending Balance $ 459 $ 2,025 $ 1,007 $ 86 $ 3,577 The following tables detail the recorded allowance for loan losses and the investment in loans related to each portfolio segment, disaggregated on the basis of impairment evaluation methodology: September 30, 2015 Construction & Owner Commercial Commercial Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 1,032 $ 924 $ — $ 1,956 Loans collectively evaluated for impairment 1,180 1,059 1,312 646 4,197 Total allowance for loan losses $ 1,180 $ 2,091 $ 2,236 $ 646 $ 6,153 Loans receivable 1 Loans individually evaluated for impairment $ — $ 15,164 $ 9,824 $ — $ 24,988 Loans collectively evaluated for impairment 25,425 111,288 88,228 9,354 234,295 Total loans receivable $ 25,425 $ 126,452 $ 98,052 $ 9,354 $ 259,283 December 31, 2014 Construction Owner Commercial Commercial Total Allowance for Loan Losses: Loans individually evaluated for impairment $ — $ 1,051 $ 676 $ — $ 1,727 Loans collectively evaluated for impairment 586 1,240 693 161 2,680 Total allowance for loan losses $ 586 $ 2,291 $ 1,369 $ 161 $ 4,407 Loans Receivable 1 Loans individually evaluated for impairment $ — $ 15,018 $ 9,984 $ — $ 25,002 Loans collectively evaluated for impairment 9,526 96,602 71,073 1,248 178,449 Total loans receivable $ 9,526 $ 111,620 $ 81,057 $ 1,248 $ 203,451 1 Loans receivable includes $21.8 million of U.S. government guaranteed loans as of September 30, 2015, of which $19.5 million are included in loans individually evaluated for impairment and $2.3 million are included in loans collectively evaluated for impairment, as presented above. As of December 31, 2014, loans receivable includes $21.3 million of U.S. government guaranteed loans, of which $19.5 million are included in loans individually evaluated for impairment and $2.0 million are included in loans collectively evaluated for impairment, as presented above.
Summary of Loans Individually Evaluated for Impairment	Loans individually evaluated for impairment as of the dates presented are summarized in the following tables. September 30, 2015 Recorded Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 4,155 $ 3,290 $ 865 Independent Pharmacies 2,279 1,679 600 Veterinary Industry 3,390 2,979 411 Total 9,824 7,948 1,876 Owner Occupied Commercial Real Estate Death Care Management 1,477 1,309 168 Healthcare 2,498 1,990 508 Veterinary Industry 11,189 8,252 2,937 Total 15,164 11,551 3,613 Total $ 24,988 $ 19,499 $ 5,489 December 31, 2014 Recorded Guaranteed Unguaranteed Commercial & Industrial Healthcare $ 4,205 $ 3,540 $ 665 Independent Pharmacies 2,199 1,492 707 Veterinary Industry 3,580 3,113 467 Total 9,984 8,145 1,839 Owner Occupied Commercial Real Estate Death Care Management 1,720 1,505 215 Healthcare 2,309 1,919 390 Veterinary Industry 10,715 7,456 3,259 Other Industries 274 274 — Total 15,018 11,154 3,864 Total $ 25,002 $ 19,299 $ 5,703
Schedule of Evaluated Balances of Loans Classified as Impaired	The following table presents evaluated balances of loans classified as impaired at the dates presented that carried an associated reserve as compared to those with no reserve. The recorded investment includes accrued interest and net deferred loan fees or costs. September 30, 2015 Recorded Investment With a With No Total Unpaid Related Commercial & Industrial Healthcare $ 4,152 $ 3 $ 4,155 $ 4,324 $ 483 Independent Pharmacies 2,091 188 2,279 2,668 335 Veterinary Industry 3,352 38 3,390 4,069 106 Total Commercial & Industrial 9,595 229 9,824 11,061 924 Owner Occupied Commercial Real Estate Death Care Management 1,477 — 1,477 1,613 11 Healthcare 2,361 137 2,498 2,606 65 Veterinary Industry 10,743 446 11,189 12,042 956 Total Owner Occupied Commercial Real Estate 14,581 583 15,164 16,261 1,032 Total Impaired Loans $ 24,176 $ 812 $ 24,988 $ 27,322 $ 1,956 December 31, 2014 Recorded Investment With a With No Total Unpaid Related Commercial & Industrial Healthcare $ 4,202 $ 3 $ 4,205 $ 4,854 $ 361 Independent Pharmacies 2,005 194 2,199 2,497 206 Veterinary Industry 3,540 40 3,580 4,062 109 Total Commercial & Industrial 9,747 237 9,984 11,413 676 Owner Occupied Commercial Real Estate Death Care Management 1,720 — 1,720 1,856 20 Healthcare 2,268 41 2,309 2,413 82 Veterinary Industry 9,796 919 10,715 11,571 947 Other Industries 274 — 274 367 2 Total Owner Occupied Commercial Real Estate 14,058 960 15,018 16,207 1,051 Total Impaired Loans $ 23,805 $ 1,197 $ 25,002 $ 27,620 $ 1,727 Three months ended Three months ended Average Interest Average Interest Commercial & Industrial Healthcare $ 3,460 $ 24 $ 2,783 $ — Independent Pharmacies 2,395 13 818 5 Veterinary Industry 3,790 5 2,910 36 Total Commercial & Industrial 9,645 42 6,511 41 Owner Occupied Commercial Real Estate Death Care Management 1,412 — — — Healthcare 2,474 — 2,426 — Veterinary Industry 11,412 42 10,217 81 Total Owner Occupied Commercial Real Estate 15,298 42 12,643 81 Total $ 24,943 $ 84 $ 19,154 $ 122 Nine months ended Nine months ended Average Interest Average Interest Commercial & Industrial Healthcare $ 3,388 $ 72 $ 2,051 $ 1 Independent Pharmacies 2,524 38 361 8 Veterinary Industry 3,482 13 3,714 63 Total Commercial & Industrial 9,394 123 6,126 72 Owner Occupied Commercial Real Estate Death Care Management 1,461 — — — Healthcare 2,372 — 2,047 — Veterinary Industry 11,357 132 10,971 252 Total Owner Occupied Commercial Real Estate 15,190 132 13,018 252 Total $ 24,584 $ 255 $ 19,144 $ 324
Summary of Types of Troubled Debt Restructurings	The following table represent the types of TDRs that were made during the periods presented: Three months ended September 30, 2015 Three months ended September 30, 2014 All Restructurings All Restructurings Number of Pre- Post- Number of Pre- Post- Interest Only Commercial & Industrial Independent Pharmacies — $ — $ — 1 $ 144 $ 143 Total Interest Only — — — 1 144 143 Extended Amortization Commercial & Industrial Independent Pharmacies 2 322 313 — — — Total Extended Amortization 2 322 313 — — — Payment Deferral Owner Occupied Commercial Real Estate Deathcare Management — — — 1 353 217 Total Payment Deferral — — — 1 353 217 Total 2 $ 322 $ 313 2 $ 497 $ 360 Nine months ended September 30, 2015 Nine months ended September 30, 2014 All Restructurings All Restructurings Number of Pre- modification Recorded Post- Number of Pre- Post- Interest Only Commercial & Industrial Healthcare 3 $ 1,093 $ 1,093 — $ — $ — Independent Pharmacies — — — 1 144 143 Owner Occupied Commercial Real Estate Healthcare 1 95 95 — — — Veterinary Industry — — — 1 8 8 Total Interest Only 4 1,188 1,188 2 152 151 Extended Amortization Commercial & Industrial Independent Pharmacies 2 322 313 2 379 367 Total Extended Amortization 2 322 313 2 379 367 Payment Deferral Commercial & Industrial Veterinary Industry — — — 3 219 216 Owner Occupied Commercial Real Estate Deathcare Management — — — 1 353 217 Total Payment Deferral — — — 4 572 433 Total 6 $ 1,510 $ 1,501 8 $ 1,103 $ 951

Servicing Assets (Tables)

Servicing Assets (Tables)	9 Months Ended
	Sep. 30, 2015
Transfers and Servicing [Abstract]
Summary of Activity Pertaining to Servicing Rights	The following summarizes the activity pertaining to servicing rights: Three Months Ended Nine Months Ended 2015 2014 2015 2014 Balance at beginning of period $ 39,983 $ 33,181 $ 34,999 $ 29,053 Additions, net 3,613 2,902 10,322 7,653 Changes in fair value (3,006 ) (984 ) (4,731 ) (1,607 ) Balance at end of period $ 40,590 $ 35,099 $ 40,590 $ 35,099

Borrowings (Tables)

Borrowings (Tables)	9 Months Ended
	Sep. 30, 2015
Debt Disclosure [Abstract]
Schedule of Total Outstanding Short and Long-Term Borrowings	Total outstanding short and long term borrowings consisted of the following: September 30, December 31, Short term borrowings On September 18, 2014, the Company entered into a line of credit of $6.1 million with an unaffiliated commercial bank, secured by 1,900,000 shares of common stock of nCino, Inc., a former subsidiary of the Company. At December 31, 2014 there was $6.1 million advanced on the line of credit. Interest accrues at 30 day LIBOR (0.16% at December 31, 2014) plus 3.50% for a term of 12 months. Payments are interest only with all principal and accrued interest due on September 18, 2015. This loan was repaid in full on February 23, 2015. $ — $ 6,100 Total short term borrowings $ — $ 6,100 Long term borrowings In April 2011, the Company elected to participate in the U.S. Treasury’s Small Business Lending Fund program (“SBLF”) whereby the U.S. Treasury agreed to purchase $6.8 million in senior securities. During the initial interest period the applicable interest rate was set at 1.5%. For all remaining interest periods, which commenced on January 1, 2012, the interest rate is determined based on a formula which encompasses the percentage change in qualified lending as well as a non-qualifying portion percentage. This rate can range from 1.5% to 10.8%. At September 30, 2015 the interest rate was 1.50%. Interest is payable quarterly in arrears. With the approval of the Company’s regulator, the Company may exit the Small Business Lending Fund at any time simply by repaying the funding provided along with any accrued but unpaid interest. If the institution wishes to repay its SBLF funding in partial payments, each partial payment must be at least 25% of the original funding amount. All senior securities will mature on September 13, 2021 at which time all principal and accrued interest will be due. $ 6,800 $ 6,800 On May 12, 2014, Independence Aviation financed the purchase of an airplane by entering into a promissory note with an unaffiliated commercial bank in the amount of $6 million which carries a fixed rate of 4.97% for a term of 59 months. Monthly payments are set at $48 thousand with all principal and accrued interest due on May 12, 2019. 5,631 5,842 On September 11, 2014, the Company financed the construction of an additional building located on the Company’s Tiburon Drive main campus for a $24 million construction line of credit with an unaffiliated commercial bank, secured by both properties at its Tiburon Drive main facility location. Payments are interest only through September 11, 2016 at a fixed rate of 3.95% for a term of 84 months. Monthly principal and interest payments beginning in October 2016 will be $146 thousand with all principal and accrued interest due on September 11, 2021. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. The construction line is fully disbursed and there was no remaining available credit on this construction line at September 30, 2015. 24,000 16,914 On September 18, 2014, the Company entered into a note payable revolving line of credit of $8.1 million with an unaffiliated commercial bank, with the first advance of $5 million on December 14, 2014. The note is unsecured and accrues interest at LIBOR plus 3.50% for a term of 36 months. The current rate is 3.693%. Payments are interest only with all principal and accrued interest due on September 18, 2017. There is no outstanding balance at September 30, 2015; therefore, there is $8.1 million of available credit on this note at September 30, 2015. — 5,000 On August 1, 2014, the Company entered into a note payable line of credit of $15 million with an unaffiliated commercial bank, secured by 100% of Live Oak Banking Company’s outstanding common stock. Interest accrues at LIBOR plus 4.00% for a term of 36 months. Payments are interest only with all principal and accrued interest due on August 1, 2017. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. This note was repaid in full on July 29, 2015. — 7,210 On March 10, 2015, Independence Aviation refinanced an existing loan with Live Oak Banking Company and entered into a new loan with an unaffiliated commercial bank in the amount of $1.2 million which carries a fixed rate of 4.96% for a term of 51 months. Monthly payments are set at $9 thousand with all principal and accrued interest due on June 10, 2019. 1,173 — On February 23, 2015 the Company transferred two related party loans to an unaffiliated commercial bank in exchange for $4.7 million. The exchange price equated to the unpaid principal balance plus accrued but uncollected interest at the time of transfer. The terms of the transfer agreement with the unaffiliated commercial bank identified the transaction as a secured borrowing for accounting purposes. Interest accrues at prime plus 1% with monthly principal and interest payments over a term of 60 months. The interest rate at September 30, 2015 is 4.25%. The maturity date is October 5, 2019. The pledged collateral is classified in other assets with a fair value of $4.5 million at September 30, 2015. Underlying loans carry a risk grade of 3 and are current with no delinquencies. The terms of this loan require the Company to maintain minimum capital, liquidity and Texas ratios. 4,475 — With the acquisition of GLS on September 1, 2013, the Company assumed the obligation to pay a former GLS partner $250 thousand at $10 thousand a month over a 24 month period. This obligation was paid in full on August 17, 2015. — 83 Total long term borrowings $ 42,079 $ 41,849

Fair Value of Financial Instr23

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2015
Unobservable Inputs Used in Level 3 Assets and Liabilities Measured at Fair Value on Recurring or Non-recurring Basis	For Level 3 assets and liabilities measured at fair value on a recurring or non-recurring basis as of September 30, 2015 and December 31, 2014 the significant unobservable inputs used in the fair value measurements were as follows: September 30, 2015 Level 3 Assets with Significant Fair Value Valuation Technique Significant Range Impaired Loans $ 22,224 Discounted appraisals Appraisal adjustments (1) 10% to 20% Foreclosed Assets $ 48 Discounted appraisals Appraisal adjustments (1) 10% to 20% December 31, 2014 Level 3 Assets with Significant Fair Value Valuation Technique Significant Range Impaired Loans $ 24,016 Discounted appraisals Appraisal adjustments (1) 10% to 20% Foreclosed Assets $ 371 Discounted appraisals Appraisal adjustments (1) 10% to 20% (1) Appraisals may be adjusted by management for customized discounting criteria, estimated sales costs, and proprietary qualitative adjustments.
Carrying Amount and Estimated Fair Value of Financial Instruments	The carrying amounts and estimated fair values of the Company’s financial instruments are as follows: September 30, 2015 Carrying Quoted Price Significant Significant Total Fair Value Financial assets Cash and due from banks $ 129,881 $ 129,881 $ — $ — $ 129,881 Certificates of deposit with other banks 10,000 9,984 — — 9,984 Investment securities, available-for-sale 51,628 — 51,628 — 51,628 Loans held for sale 443,871 — — 458,780 458,780 Loans, net of allowance for loan losses 253,399 — — 247,906 247,906 Servicing assets 40,590 — — 40,590 40,590 Accrued interest receivable 4,841 4,841 — — 4,841 Financial liabilities Deposits 762,628 — 754,715 — 754,715 Accrued interest payable 243 243 — — 243 Long term borrowings 42,079 — — 44,987 44,987 December 31, 2014 Carrying Quoted Price Significant Significant Total Fair Value Financial assets Cash and due from banks $ 29,902 $ 29,902 $ — $ — $ 29,902 Certificates of deposit with other banks 10,000 9,861 — — 9,861 Investment securities, available-for-sale 49,318 — 49,318 — 49,318 Loans held for sale 295,180 — — 304,504 304,504 Loans, net of allowance for loan losses 199,529 — — 194,007 194,007 Servicing assets 34,999 — — 34,999 34,999 Accrued interest receivable 3,059 3,059 — — 3,059 Financial liabilities Deposits 522,080 — 522,058 — 522,058 Accrued interest payable 190 190 — — 190 Short term borrowings 6,100 — — 6,100 6,100 Long term borrowings 41,849 — — 44,738 44,738
Recurring Fair Value [Member]
Assets and Liabilities Measured at Fair Value on Recurring Basis and Non-recurring Basis	The tables below present the recorded amount of assets and liabilities measured at fair value on a recurring basis. September 30, 2015 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 27,213 $ — $ 27,213 $ — Residential mortgage-backed securities 22,466 — 22,466 — Mutual fund 1,949 — 1,949 — Servicing assets 1 40,590 — — 40,590 Total assets at fair value $ 92,218 $ — $ 51,628 $ 40,590 December 31, 2014 Total Level 1 Level 2 Level 3 Investment securities available-for-sale US government agencies $ 35,309 $ — $ 35,309 $ — Residential mortgage-backed securities 14,009 — 14,009 — Servicing assets 1 34,999 — — 34,999 Total assets at fair value $ 84,317 $ — $ 49,318 $ 34,999 1 See Note 6 for a rollforward of recurring Level 3 fair values for servicing assets.
Non-recurring Fair Value [Member]
Assets and Liabilities Measured at Fair Value on Recurring Basis and Non-recurring Basis	The tables below present the recorded amount of assets and liabilities measured at fair value on a non-recurring basis. September 30, 2015 Total Level 1 Level 2 Level 3 Impaired loans $ 22,224 $ — $ — $ 22,224 Foreclosed assets 48 — — 48 Total assets at fair value $ 22,272 $ — $ — $ 22,272 December 31, 2014 Total Level 1 Level 2 Level 3 Impaired loans $ 24,016 $ — $ — $ 24,016 Foreclosed assets 371 — — 371 Total assets at fair value $ 24,387 $ — $ — $ 24,387

Commitments and Contingencies (

Commitments and Contingencies (Tables)	9 Months Ended
	Sep. 30, 2015
Commitments and Contingencies Disclosure [Abstract]
Schedule of Commitments	A summary of the Company’s commitments is as follows: September 30, December 31, Commitments to extend credit $ 747,909 $ 537,951 Plexus Capital - Fund II Investment Commitment 100 100 Plexus Capital - Fund III Investment Commitment 300 350 Total unfunded off-balance sheet credit risk $ 748,309 $ 538,401

Stock Plans (Tables)

Stock Plans (Tables)	9 Months Ended
	Sep. 30, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Summary of Stock Option Activity	Stock option activity under the plan during the nine month periods ended September 30, 2015 and 2014 is summarized below. Shares Weighted Weighted Aggregate Outstanding at December 31, 2014 1,737,570 $ 5.51 Exercised 47,570 4.52 Forfeited 192,671 8.38 Granted 1,829,748 15.52 Outstanding at September 30, 2015 3,327,077 $ 10.86 9.16 years $ 29,197,309 Exercisable at September 30, 2015 158,950 $ 4.65 8.05 years $ 2,382,744 Shares Weighted Weighted Aggregate Outstanding at December 31, 2013 225,000 $ 1.01 Exercised 191,660 0.92 Forfeited 170,590 4.40 Granted 1,874,820 5.48 Outstanding at September 30, 2014 1,737,570 $ 5.51 9.54 years $ 8,902,969 Exercisable at September 30, 2014 22,227 $ 1.52 7.04 years $ 202,486
Summary of Non-vested Stock Option Activity	The following is a summary of non-vested stock option activity for the Company for the nine months ended September 30, 2015 and 2014. Shares Weighted Non-vested at December 31, 2014 1,704,230 $ 1.18 Granted 1,829,748 6.79 Vested 173,180 0.97 Forfeited 192,671 2.63 Non-vested at September 30, 2015 3,168,127 $ 4.35 Shares Weighted Non-vested at December 31, 2013 91,754 $ 0.44 Granted 1,874,820 1.13 Vested 80,641 0.44 Forfeited 170,590 0.58 Non-vested at September 30, 2014 1,715,343 $ 1.18
Summary of Restricted Stock Activity	Restricted stock activity under the plan during the first nine months of 2015 is summarized below. Shares Weighted Outstanding at December 31, 2014 — $ — Granted 65,122 16.10 Vested — — Exercised — — Forfeited 607 10.63 Non-vested at September 30, 2015 64,515 $ 16.15

Basis of Presentation - Additio

Basis of Presentation - Additional Information (Detail) $ in Thousands	9 Months Ended
	Sep. 30, 2015USD ($)Segment	Feb. 02, 2015USD ($)
Summary of Accounting and Financial Policies [Line Items]
Ownership percentage after additional acquisition	92.40%	91.30%
Additional acquisition percentage		41.30%
Contingent consideration in acquisition of controlling interest in equity method of investment | $	$ 170	$ 170
Ownership percentage with noncontrolling owners		7.60%
Common stock, stock split	Ten-for-one stock
Common stock, stock split ratio	10
Number of operating segments	1
Five Zero four FA [Member]
Summary of Accounting and Financial Policies [Line Items]
Equity ownership percentage		50.00%

Earnings Per Share - Schedule o

Earnings Per Share - Schedule of Basic and Diluted Earnings Per Share Computed Based on Weighted Average Number of Shares Outstanding (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Basic earnings per share:
Net income available to common shareholders	$ 2,901	$ 641	$ 14,910	$ 7,600
Weighted-average basic shares outstanding	32,824,587	25,632,505	30,037,436	22,412,646
Basic earnings per share	$ 0.09	$ 0.03	$ 0.50	$ 0.34
Diluted earnings per share:
Net income available to common shareholders, for diluted earnings per share	$ 2,901	$ 641	$ 14,910	$ 7,600
Total weighted-average basic shares outstanding	32,824,587	25,632,505	30,037,436	22,412,646
Add effect of dilutive stock options and restricted stock grants	1,092,695	603,195	892,794	286,789
Total weighted-average diluted shares outstanding	33,917,282	26,235,700	30,930,230	22,699,435
Diluted earnings per share	$ 0.09	$ 0.02	$ 0.48	$ 0.33
Anti-dilutive shares	1,391,828	328,210	1,562,168	328,210

Earnings Per Share - Additional

Earnings Per Share - Additional information (Detail)	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Earnings Per Share [Abstract]
Effective tax rate	38.50%	38.50%

Earnings Per Share - Schedule29

Earnings Per Share - Schedule of Proforma for Income Tax Expense and Earnings Per Share (Detail) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014
Earnings Per Share ProForma [Line Items]
Pro forma basic earnings per share	$ 0.16	$ 0.37
Pro forma diluted earnings per share	$ 0.16	$ 0.37
Pro Forma [Member]
Earnings Per Share ProForma [Line Items]
Pro forma net income available to common shareholders, after tax	$ 4,071	$ 8,349

Securities - Summary of Carryin

Securities - Summary of Carrying Amount and Fair Value of Securities (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Mar. 31, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	$ 51,487		$ 49,180
Unrealized Gains	277		219
Unrealized Losses	136		81
Fair Value	51,628		49,318	[1]
US Government Agencies [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	26,987		35,207
Unrealized Gains	226		127
Unrealized Losses			25
Fair Value	27,213		35,309
Residential Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	22,570		13,973
Unrealized Gains	32		92
Unrealized Losses	136		56
Fair Value	22,466		$ 14,009
Mutual Fund [Member]
Schedule of Available-for-sale Securities [Line Items]
Amortized Cost	1,930
Unrealized Gains	19
Fair Value	$ 1,949	$ 1,900
[1]	Derived from audited consolidated financial statements.

Securities - Additional Informa

Securities - Additional Information (Detail) $ / shares in Units, $ in Thousands	3 Months Ended				9 Months Ended
	Sep. 30, 2015USD ($)Securitiesshares	Jun. 30, 2015USD ($)Securities	Mar. 31, 2015USD ($)Securities	Sep. 30, 2014USD ($)Securities	Sep. 30, 2015USD ($)Securities$ / sharesshares	Sep. 30, 2014USD ($)Securities	Dec. 31, 2014USD ($)Securities
Schedule of Available-for-sale Securities [Line Items]
Investment at current market value	$ 51,628				$ 51,628		$ 49,318	[1]
Mortgage-backed securities					15,437	$ 31,482
Private placement, proceeds						$ 74,631
Greater than 12 months in unrealized loss position, Number of securities | Securities							6
Investment securities, fair market value	$ 1,300				1,300		$ 1,300
US Government Agencies [Member]
Schedule of Available-for-sale Securities [Line Items]
Number of mortgage-backed securities sold | Securities	3
Sale of securities	$ 8,300
Gain on sale of securities	12
Number of mortgage-backed securities purchased | Securities				5
Investment at current market value	$ 27,213				27,213		$ 35,309
Mortgage-backed securities				$ 29,900
Private placement, proceeds				74,600
Greater than 12 months in unrealized loss position, Number of securities | Securities							1
Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Number of mortgage-backed securities sold | Securities			6
Number of mortgage-backed securities purchased | Securities	4	2				1
Mortgage-backed securities			$ 3,400
Four Mortgage-Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage-backed securities	$ 9,500				9,500
Mutual Fund [Member]
Schedule of Available-for-sale Securities [Line Items]
Investment at current market value	$ 1,949		$ 1,900		$ 1,949
Number of securities purchased | shares	190,380.762				190,380.762
Securities purchased, price per share | $ / shares					$ 9.98
Two Mortgage Backed Securities Purchased [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage-backed securities		$ 4,000
Residential Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Investment at current market value	$ 22,466				$ 22,466		$ 14,009
Greater than 12 months in unrealized loss position, Number of securities | Securities	3				3		5
Less than 12 months in unrealized loss position, Number of securities | Securities	9				9		1
One Mortgage Backed Securities Purchased [Member]
Schedule of Available-for-sale Securities [Line Items]
Mortgage-backed securities				$ 1,600		$ 1,600
Dividend Reinvestment [Member]
Schedule of Available-for-sale Securities [Line Items]
Investment at current market value	$ 30				$ 30
[1]	Derived from audited consolidated financial statements.

Securities - Summary of Gross U

Securities - Summary of Gross Unrealized Losses and Fair Value (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less Than 12 Months	$ 14,453	$ 2,234
Unrealized Losses, Less Than 12 Months	114	4
Fair Value, 12 Months or More	3,269	6,382
Unrealized Losses, 12 Months or More	22	77
Total Fair Value	17,722	8,616
Total Unrealized Losses	136	81
US Government Agencies [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair Value, 12 Months or More		1,224
Unrealized Losses, 12 Months or More		25
Total Fair Value		1,224
Total Unrealized Losses		25
Residential Mortgage Backed Securities [Member]
Schedule of Available-for-sale Securities [Line Items]
Fair Value, Less Than 12 Months	14,453	2,234
Unrealized Losses, Less Than 12 Months	114	4
Fair Value, 12 Months or More	3,269	5,158
Unrealized Losses, 12 Months or More	22	52
Total Fair Value	17,722	7,392
Total Unrealized Losses	$ 136	$ 56

Securities - Summary of Investm

Securities - Summary of Investment Securities by Maturity (Detail) $ in Thousands	Sep. 30, 2015USD ($)
Available-for-sale Securities, Debt Maturities [Abstract]
One to five years, Amortized Cost	$ 26,987
Five to ten years, Amortized Cost	10,052
After 10 years, Amortized Cost	12,518
Total, Amortized Cost	49,557
One to five years, Fair Value	27,213
Five to ten years, Fair Value	10,057
After 10 years, Fair Value	12,409
Available for sale, Fair Value, Total	$ 49,679

Loans and Allowance for Loan 34

Loans and Allowance for Loan Losses - Summary of Loans (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 259,283	$ 203,451
Net Deferred Costs	2,685	2,060
Discount on SBA 7(a) Unguaranteed	(2,416)	(1,575)
Loans, Net of Unearned	259,552	203,936	[1]
Commercial & Industrial [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	98,052	81,057
Commercial & Industrial [Member] | Agricultural [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	30
Commercial & Industrial [Member] | Death Care Management [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	4,831	3,603
Commercial & Industrial [Member] | Health Care [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	13,563	12,319
Commercial & Industrial [Member] | Independent Pharmacies [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	41,123	34,079
Commercial & Industrial [Member] | Registered Investment Advisors [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	16,304	9,660
Commercial & Industrial [Member] | Veterinary Industry [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	20,985	20,902
Commercial & Industrial [Member] | Other Industries [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	1,216	494
Construction & Development [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	25,425	9,526
Construction & Development [Member] | Agricultural [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	12,233	3,910
Construction & Development [Member] | Death Care Management [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	991	92
Construction & Development [Member] | Health Care [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	7,722	2,957
Construction & Development [Member] | Independent Pharmacies [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	687	215
Construction & Development [Member] | Registered Investment Advisors [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	75
Construction & Development [Member] | Veterinary Industry [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	3,038	2,207
Construction & Development [Member] | Other Industries [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	679	145
Owner Occupied Commercial Real Estate [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	126,452	111,620
Owner Occupied Commercial Real Estate [Member] | Agricultural [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	125	259
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	19,575	18,879
Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	33,342	26,173
Owner Occupied Commercial Real Estate [Member] | Independent Pharmacies [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	5,752	4,750
Owner Occupied Commercial Real Estate [Member] | Registered Investment Advisors [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	2,981	2,161
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	61,092	57,934
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	3,585	1,464
Commercial Land [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	9,354	1,248
Commercial Land [Member] | Agricultural [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 9,354	$ 1,248
[1]	Derived from audited consolidated financial statements.

Loans and Allowance for Loan 35

Loans and Allowance for Loan Losses - Summary of Loans (Parenthetical) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 259,283	$ 203,451
Loans Insured or Guaranteed by US Government Authorities [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Total Loans	$ 21,800	$ 21,300

Loans and Allowance for Loan 36

Loans and Allowance for Loan Losses - Additional Information (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015USD ($)	Sep. 30, 2014USD ($)	Sep. 30, 2015USD ($)Score	Sep. 30, 2014USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loans and Leases Receivable, Impaired, Interest Lost on Nonaccrual Loans | $	$ 358	$ 56	$ 665	$ 147
Recorded investment | $		$ 217		$ 217
Loans (1 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	175.00%		175.00%
Maximum [Member] | Loans (1 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan-to-value ratio	65.00%		65.00%
Maximum [Member] | Loans (2 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Loan-to-value ratio	75.00%		75.00%
Maximum [Member] | Loans (4 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Cash flow coverage			100.00%
Minimum [Member] | Loans (1 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Discounted collateral coverage			125.00%
Credit score			740
Minimum [Member] | Loans (3 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	100.00%		100.00%
Minimum [Member] | Loans (2 Rated) [Member]
Accounts, Notes, Loans and Financing Receivable [Line Items]
Debt service coverage	125.00%		125.00%
Discounted collateral coverage			100.00%
Credit score			700

Loans and Allowance for Loan 37

Loans and Allowance for Loan Losses - Summary of Risk Grades of Each Category of Loans (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment [Line Items]
Total Loans	$ 259,283	$ 203,451
Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	216,786	162,434
Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,624	9,765
Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	32,873	31,252
Commercial & Industrial [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	98,052	81,057
Commercial & Industrial [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	80,454	63,777
Commercial & Industrial [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,897	4,546
Commercial & Industrial [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	13,701	12,734
Commercial & Industrial [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	30
Commercial & Industrial [Member] | Agricultural [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	30
Commercial & Industrial [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	4,831	3,603
Commercial & Industrial [Member] | Death Care Management [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	4,727	3,603
Commercial & Industrial [Member] | Death Care Management [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	104
Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	13,563	12,319
Commercial & Industrial [Member] | Health Care [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	8,007	6,995
Commercial & Industrial [Member] | Health Care [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	556	538
Commercial & Industrial [Member] | Health Care [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,000	4,786
Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	41,123	34,079
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	34,795	27,673
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,173	2,726
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	4,155	3,680
Commercial & Industrial [Member] | Registered Investment Advisors [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	16,304	9,660
Commercial & Industrial [Member] | Registered Investment Advisors [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	15,952	9,660
Commercial & Industrial [Member] | Registered Investment Advisors [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	352
Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	20,985	20,902
Commercial & Industrial [Member] | Veterinary Industry [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	15,873	15,513
Commercial & Industrial [Member] | Veterinary Industry [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	566	1,121
Commercial & Industrial [Member] | Veterinary Industry [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	4,546	4,268
Commercial & Industrial [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,216	494
Commercial & Industrial [Member] | Other Industries [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,070	333
Commercial & Industrial [Member] | Other Industries [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	146	161
Construction & Development [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	25,425	9,526
Construction & Development [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	25,333	9,526
Construction & Development [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	92
Construction & Development [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	12,233	3,910
Construction & Development [Member] | Agricultural [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	12,141	3,910
Construction & Development [Member] | Agricultural [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	92
Construction & Development [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	991	92
Construction & Development [Member] | Death Care Management [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	991	92
Construction & Development [Member] | Health Care [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	7,722	2,957
Construction & Development [Member] | Health Care [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	7,722	2,957
Construction & Development [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	687	215
Construction & Development [Member] | Independent Pharmacies [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	687	215
Construction & Development [Member] | Registered Investment Advisors [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	75
Construction & Development [Member] | Registered Investment Advisors [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	75
Construction & Development [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,038	2,207
Construction & Development [Member] | Veterinary Industry [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,038	2,207
Construction & Development [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	679	145
Construction & Development [Member] | Other Industries [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	679	145
Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	126,452	111,620
Owner Occupied Commercial Real Estate [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	101,645	87,883
Owner Occupied Commercial Real Estate [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,635	5,219
Owner Occupied Commercial Real Estate [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	19,172	18,518
Owner Occupied Commercial Real Estate [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	125	259
Owner Occupied Commercial Real Estate [Member] | Agricultural [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	125	259
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	19,575	18,879
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	17,041	16,519
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	832	639
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,702	1,721
Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	33,342	26,173
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	28,804	22,778
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,716	938
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,822	2,457
Owner Occupied Commercial Real Estate [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,752	4,750
Owner Occupied Commercial Real Estate [Member] | Independent Pharmacies [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	5,355	4,709
Owner Occupied Commercial Real Estate [Member] | Independent Pharmacies [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	397	41
Owner Occupied Commercial Real Estate [Member] | Registered Investment Advisors [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,981	2,161
Owner Occupied Commercial Real Estate [Member] | Registered Investment Advisors [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,981	2,161
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	61,092	57,934
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	43,754	40,281
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	2,690	3,601
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	14,648	14,052
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,585	1,464
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	3,585	1,176
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans		288
Commercial Land [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,354	1,248
Commercial Land [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,354	1,248
Commercial Land [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,354	1,248
Commercial Land [Member] | Agricultural [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	$ 9,354	$ 1,248

Loans and Allowance for Loan 38

Loans and Allowance for Loan Losses - Summary of Risk Grades of Each Category of Loans (Parenthetical) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment [Line Items]
Total Loans	$ 259,283	$ 203,451
Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	216,786	162,434
Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	9,624	9,765
Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	32,873	31,252
Loans Insured or Guaranteed by US Government Authorities [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	21,800	21,300
Loans Insured or Guaranteed by US Government Authorities [Member] | Risk Grades 1- 4 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	0	0
Loans Insured or Guaranteed by US Government Authorities [Member] | Risk Grade 5 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	1,100	1,100
Loans Insured or Guaranteed by US Government Authorities [Member] | Risk Grades 6 - 8 [Member]
Financing Receivable, Recorded Investment [Line Items]
Total Loans	$ 20,700	$ 20,200

Loans and Allowance for Loan 39

Loans and Allowance for Loan Losses - Summary of Age Analysis of Past Due Loans (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	$ 24,710	$ 25,371
Current Loans	234,573	178,080
Total Loans	259,283	203,451
Loans 90 Days or More Past Due & Still Accruing	0	0
Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	12,707	12,786
Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	4,865	3,489
30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	6,327	6,679
30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	811	2,417
Commercial & Industrial [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	7,823	8,566
Current Loans	90,229	72,491
Total Loans	98,052	81,057
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	5,748	5,872
Commercial & Industrial [Member] | Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	427	1,025
Commercial & Industrial [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	1,002	1,433
Commercial & Industrial [Member] | 30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	646	236
Commercial & Industrial [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	30
Total Loans	30
Loans 90 Days or More Past Due & Still Accruing	0
Commercial & Industrial [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	4,831	3,603
Total Loans	4,831	3,603
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,598	3,711
Current Loans	10,965	8,608
Total Loans	13,563	12,319
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial [Member] | Health Care [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,321	2,420
Commercial & Industrial [Member] | Health Care [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	277	1,059
Commercial & Industrial [Member] | Health Care [Member] | 30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans		232
Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,098	1,322
Current Loans	39,025	32,757
Total Loans	41,123	34,079
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	1,170	1,224
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	313
Commercial & Industrial [Member] | Independent Pharmacies [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	615	98
Commercial & Industrial [Member] | Registered Investment Advisors [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	16,304	9,660
Total Loans	16,304	9,660
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	3,127	3,533
Current Loans	17,858	17,369
Total Loans	20,985	20,902
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial & Industrial [Member] | Veterinary Industry [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,257	2,228
Commercial & Industrial [Member] | Veterinary Industry [Member] | Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	114	1,025
Commercial & Industrial [Member] | Veterinary Industry [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	110	276
Commercial & Industrial [Member] | Veterinary Industry [Member] | 30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	646	4
Commercial & Industrial [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	1,216	494
Total Loans	1,216	494
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	46
Current Loans	25,379	9,526
Total Loans	25,425	9,526
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	46
Construction & Development [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	12,233	3,910
Total Loans	12,233	3,910
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	991	92
Total Loans	991	92
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member] | Health Care [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	46
Current Loans	7,676	2,957
Total Loans	7,722	2,957
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member] | Health Care [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	46
Construction & Development [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	687	215
Total Loans	687	215
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member] | Registered Investment Advisors [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	75
Total Loans	75
Loans 90 Days or More Past Due & Still Accruing	0
Construction & Development [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	3,038	2,207
Total Loans	3,038	2,207
Loans 90 Days or More Past Due & Still Accruing	0	0
Construction & Development [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	679	145
Total Loans	679	145
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	16,841	16,805
Current Loans	109,611	94,815
Total Loans	126,452	111,620
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	6,959	6,914
Owner Occupied Commercial Real Estate [Member] | Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	4,438	2,464
Owner Occupied Commercial Real Estate [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	5,279	5,246
Owner Occupied Commercial Real Estate [Member] | 30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	165	2,181
Owner Occupied Commercial Real Estate [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	125	259
Total Loans	125	259
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	1,479	1,721
Current Loans	18,096	17,158
Total Loans	19,575	18,879
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans		1,721
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	1,479
Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,308	2,457
Current Loans	31,034	23,716
Total Loans	33,342	26,173
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,308	2,082
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans		145
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | 30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans		230
Owner Occupied Commercial Real Estate [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	5,752	4,750
Total Loans	5,752	4,750
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Registered Investment Advisors [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	2,981	2,161
Total Loans	2,981	2,161
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	13,054	12,352
Current Loans	48,038	45,582
Total Loans	61,092	57,934
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	4,651	2,836
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Less Than 30 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	2,959	2,464
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | 30-89 Days Past Due & Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	5,279	5,101
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | 30-89 Days Past Due & Not Accruing [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans	165	1,951
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans		275
Current Loans	3,585	1,189
Total Loans	3,585	1,464
Loans 90 Days or More Past Due & Still Accruing	0	0
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Not Accruing and Past Due Loans		275
Commercial Land [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	9,354	1,248
Total Loans	9,354	1,248
Loans 90 Days or More Past Due & Still Accruing	0	0
Commercial Land [Member] | Agricultural [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Current Loans	9,354	1,248
Total Loans	9,354	1,248
Loans 90 Days or More Past Due & Still Accruing	$ 0	$ 0

Loans and Allowance for Loan 40

Loans and Allowance for Loan Losses - Summary of Age Analysis of Past Due Loans (Parenthetical) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Loans	$ 259,283	$ 203,451
Total Loans Past Due	24,710	25,371
Current Loans	234,573	178,080
Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Loans Past Due	12,707	12,786
Loans Insured or Guaranteed by US Government Authorities [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Loans	21,800	21,300
Current Loans	7,600	6,100
Loans Insured or Guaranteed by US Government Authorities [Member] | Greater Than 90 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Loans Past Due	11,100	11,700
Loans Insured or Guaranteed by US Government Authorities [Member] | 30-89 Days Past Due [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Total Loans Past Due	$ 3,100	$ 3,500

Loans and Allowance for Loan 41

Loans and Allowance for Loan Losses - Schedule of Nonaccrual Loans (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	$ 18,383	$ 18,692
Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	15,821	15,555
Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,562	3,137
Commercial & Industrial [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	6,821	7,133
Commercial & Industrial [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	6,459	6,620
Commercial & Industrial [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	362	513
Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,321	2,652
Commercial & Industrial [Member] | Health Care [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,136	2,368
Commercial & Industrial [Member] | Health Care [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	185	284
Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,483	1,224
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,344	1,139
Commercial & Industrial [Member] | Independent Pharmacies [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	139	85
Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	3,017	3,257
Commercial & Industrial [Member] | Veterinary Industry [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,979	3,113
Commercial & Industrial [Member] | Veterinary Industry [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	38	144
Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	11,562	11,559
Owner Occupied Commercial Real Estate [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	9,362	8,935
Owner Occupied Commercial Real Estate [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,200	2,624
Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	2,308	2,312
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,990	1,919
Owner Occupied Commercial Real Estate [Member] | Health Care [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	318	393
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	7,775	7,251
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	6,063	5,236
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,712	2,015
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,479	1,721
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	1,309	1,505
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member] | Unguaranteed Loan Exposure [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance	$ 170	216
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance		275
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member] | Small Business Administration [Member]
Financing Receivable, Recorded Investment, Past Due [Line Items]
Nonaccrual loans balance		$ 275

Loans and Allowance for Loan 42

Loans and Allowance for Loan Losses - Schedule of Allowance for Loan Losses by Portfolio Segment Allowance (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	$ 5,183	$ 3,568	$ 4,407	[1]	$ 2,723
Allowance for Loan Losses, Charge offs	(287)	(521)	(766)		(648)
Allowance for Loan Losses, Recoveries	45	18	173		91
Allowance for Loan Losses, Provision	1,212	512	2,339		1,411
Allowance for Loan Losses, Ending Balance	6,153	3,577	6,153		3,577
Construction & Development [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	844	300	586		350
Allowance for Loan Losses, Provision	336	159	594		109
Allowance for Loan Losses, Ending Balance	1,180	459	1,180		459
Owner Occupied Commercial Real Estate [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	2,346	1,931	2,291		1,511
Allowance for Loan Losses, Charge offs	(7)	(227)	(128)		(346)
Allowance for Loan Losses, Recoveries	12	5	100		72
Allowance for Loan Losses, Provision	(260)	316	(172)		788
Allowance for Loan Losses, Ending Balance	2,091	2,025	2,091		2,025
Commercial & Industrial [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	1,653	1,312	1,369		862
Allowance for Loan Losses, Charge offs	(280)	(294)	(638)		(302)
Allowance for Loan Losses, Recoveries	33	13	73		19
Allowance for Loan Losses, Provision	830	(24)	1,432		428
Allowance for Loan Losses, Ending Balance	2,236	1,007	2,236		1,007
Commercial Land [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Beginning Balance	340	25	161
Allowance for Loan Losses, Provision	306	61	485		86
Allowance for Loan Losses, Ending Balance	$ 646	$ 86	$ 646		$ 86
[1]	Derived from audited consolidated financial statements.

Loans and Allowance for Loan 43

Loans and Allowance for Loan Losses - Schedule of Recorded Allowance for Loan Losses and Investment in Loans Related to Each Portfolio Segment (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014		Sep. 30, 2014	Jun. 30, 2014	Dec. 31, 2013
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	$ 1,956		$ 1,727
Allowance for Loan Losses, Collectively evaluated for impairment	4,197		2,680
Total allowance for loan losses	6,153	$ 5,183	4,407	[1]	$ 3,577	$ 3,568	$ 2,723
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	24,988		25,002
Loans Receivable, Collectively evaluated for impairment	234,295		178,449
Total loans receivable	259,283		203,451
Construction & Development [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Collectively evaluated for impairment	1,180		586
Total allowance for loan losses	1,180	844	586		459	300	350
Loans Receivable :
Loans Receivable, Collectively evaluated for impairment	25,425		9,526
Total loans receivable	25,425		9,526
Owner Occupied Commercial Real Estate [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	1,032		1,051
Allowance for Loan Losses, Collectively evaluated for impairment	1,059		1,240
Total allowance for loan losses	2,091	2,346	2,291		2,025	1,931	1,511
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	15,164		15,018
Loans Receivable, Collectively evaluated for impairment	111,288		96,602
Total loans receivable	126,452		111,620
Commercial & Industrial [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Individually evaluated for impairment	924		676
Allowance for Loan Losses, Collectively evaluated for impairment	1,312		693
Total allowance for loan losses	2,236	1,653	1,369		1,007	1,312	$ 862
Loans Receivable :
Loans Receivable, Individually evaluated for impairment	9,824		9,984
Loans Receivable, Collectively evaluated for impairment	88,228		71,073
Total loans receivable	98,052		81,057
Commercial Land [Member]
Allowance for Loan Losses:
Allowance for Loan Losses, Collectively evaluated for impairment	646		161
Total allowance for loan losses	646	$ 340	161		$ 86	$ 25
Loans Receivable :
Loans Receivable, Collectively evaluated for impairment	9,354		1,248
Total loans receivable	$ 9,354		$ 1,248
[1]	Derived from audited consolidated financial statements.

Loans and Allowance for Loan 44

Loans and Allowance for Loan Losses - Schedule of Recorded Allowance for Loan Losses and Investment in Loans Related to Each Portfolio Segment (Parenthetical) (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans receivable	$ 259,283	$ 203,451
Loans Receivable, Individually evaluated for impairment	24,988	25,002
Loans Receivable, Collectively evaluated for impairment	234,295	178,449
Loans Insured or Guaranteed by US Government Authorities [Member]
Financing Receivable, Allowance for Credit Losses [Line Items]
Total loans receivable	21,800	21,300
Loans Receivable, Individually evaluated for impairment	19,500	19,500
Loans Receivable, Collectively evaluated for impairment	$ 2,300	$ 2,000

Loans and Allowance for Loan 45

Loans and Allowance for Loan Losses - Summary of Loans Individually Evaluated for Impairment (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	$ 24,988	$ 25,002
Commercial & Industrial [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	9,824	9,984
Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	4,155	4,205
Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	2,279	2,199
Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	3,390	3,580
Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	15,164	15,018
Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	2,498	2,309
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	11,189	10,715
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	1,477	1,720
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance		274
Small Business Administration [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	19,499	19,299
Small Business Administration [Member] | Commercial & Industrial [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	7,948	8,145
Small Business Administration [Member] | Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	3,290	3,540
Small Business Administration [Member] | Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	1,679	1,492
Small Business Administration [Member] | Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	2,979	3,113
Small Business Administration [Member] | Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	11,551	11,154
Small Business Administration [Member] | Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	1,990	1,919
Small Business Administration [Member] | Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	8,252	7,456
Small Business Administration [Member] | Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	1,309	1,505
Small Business Administration [Member] | Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance		274
Unguaranteed Loan Exposure [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	5,489	5,703
Unguaranteed Loan Exposure [Member] | Commercial & Industrial [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	1,876	1,839
Unguaranteed Loan Exposure [Member] | Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	865	665
Unguaranteed Loan Exposure [Member] | Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	600	707
Unguaranteed Loan Exposure [Member] | Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	411	467
Unguaranteed Loan Exposure [Member] | Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	3,613	3,864
Unguaranteed Loan Exposure [Member] | Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	508	390
Unguaranteed Loan Exposure [Member] | Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	2,937	3,259
Unguaranteed Loan Exposure [Member] | Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Impaired [Line Items]
Impaired loans, Unpaid Principal Balance	$ 168	$ 215

Loans and Allowance for Loan 46

Loans and Allowance for Loan Losses - Schedule of Evaluated Balances of Loans Classified as Impaired (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	$ 24,176		$ 24,176		$ 23,805
Recorded Investment, With No Recorded Allowance	812		812		1,197
Recorded Investment, Total	24,988		24,988		25,002
Loans, Unpaid Principal Balance	27,322		27,322		27,620
Loans, Related Allowance Recorded	1,956		1,956		1,727
Loans, Average Balance	24,943	$ 19,154	24,584	$ 19,144
Loans, Interest Income Recognized	84	122	255	324
Commercial & Industrial [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	9,595		9,595		9,747
Recorded Investment, With No Recorded Allowance	229		229		237
Recorded Investment, Total	9,824		9,824		9,984
Loans, Unpaid Principal Balance	11,061		11,061		11,413
Loans, Related Allowance Recorded	924		924		676
Loans, Average Balance	9,645	6,511	9,394	6,126
Loans, Interest Income Recognized	42	41	123	72
Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	4,152		4,152		4,202
Recorded Investment, With No Recorded Allowance	3		3		3
Recorded Investment, Total	4,155		4,155		4,205
Loans, Unpaid Principal Balance	4,324		4,324		4,854
Loans, Related Allowance Recorded	483		483		361
Loans, Average Balance	3,460	2,783	3,388	2,051
Loans, Interest Income Recognized	24		72	1
Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,091		2,091		2,005
Recorded Investment, With No Recorded Allowance	188		188		194
Recorded Investment, Total	2,279		2,279		2,199
Loans, Unpaid Principal Balance	2,668		2,668		2,497
Loans, Related Allowance Recorded	335		335		206
Loans, Average Balance	2,395	818	2,524	361
Loans, Interest Income Recognized	13	5	38	8
Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	3,352		3,352		3,540
Recorded Investment, With No Recorded Allowance	38		38		40
Recorded Investment, Total	3,390		3,390		3,580
Loans, Unpaid Principal Balance	4,069		4,069		4,062
Loans, Related Allowance Recorded	106		106		109
Loans, Average Balance	3,790	2,910	3,482	3,714
Loans, Interest Income Recognized	5	36	13	63
Owner Occupied Commercial Real Estate [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	14,581		14,581		14,058
Recorded Investment, With No Recorded Allowance	583		583		960
Recorded Investment, Total	15,164		15,164		15,018
Loans, Unpaid Principal Balance	16,261		16,261		16,207
Loans, Related Allowance Recorded	1,032		1,032		1,051
Loans, Average Balance	15,298	12,643	15,190	13,018
Loans, Interest Income Recognized	42	81	132	252
Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	2,361		2,361		2,268
Recorded Investment, With No Recorded Allowance	137		137		41
Recorded Investment, Total	2,498		2,498		2,309
Loans, Unpaid Principal Balance	2,606		2,606		2,413
Loans, Related Allowance Recorded	65		65		82
Loans, Average Balance	2,474	2,426	2,372	2,047
Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	10,743		10,743		9,796
Recorded Investment, With No Recorded Allowance	446		446		919
Recorded Investment, Total	11,189		11,189		10,715
Loans, Unpaid Principal Balance	12,042		12,042		11,571
Loans, Related Allowance Recorded	956		956		947
Loans, Average Balance	11,412	10,217	11,357	10,971
Loans, Interest Income Recognized	42	$ 81	132	$ 252
Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance	1,477		1,477		1,720
Recorded Investment, Total	1,477		1,477		1,720
Loans, Unpaid Principal Balance	1,613		1,613		1,856
Loans, Related Allowance Recorded	11		11		20
Loans, Average Balance	$ 1,412		$ 1,461
Owner Occupied Commercial Real Estate [Member] | Other Industries [Member]
Financing Receivable, Impaired [Line Items]
Recorded Investment, With a Recorded Allowance					274
Recorded Investment, Total					274
Loans, Unpaid Principal Balance					367
Loans, Related Allowance Recorded					$ 2

Loans and Allowance for Loan 47

Loans and Allowance for Loan Losses - Summary of Recorded Investment in TDR Loans (Detail) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015USD ($)SecurityLoan	Sep. 30, 2014USD ($)SecurityLoan	Sep. 30, 2015USD ($)SecurityLoan	Sep. 30, 2014USD ($)SecurityLoan
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan	2	2	6	8
TDR loans, Pre-modification Recorded Investment	$ 322	$ 497	$ 1,510	$ 1,103
TDR loans, Post-modification Recorded Investment	$ 313	$ 360	$ 1,501	$ 951
Interest Only [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan		1	4	2
TDR loans, Pre-modification Recorded Investment		$ 144	$ 1,188	$ 152
TDR loans, Post-modification Recorded Investment		$ 143	$ 1,188	$ 151
Interest Only [Member] | Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan		1		1
TDR loans, Pre-modification Recorded Investment		$ 144		$ 144
TDR loans, Post-modification Recorded Investment		$ 143		$ 143
Interest Only [Member] | Commercial & Industrial [Member] | Health Care [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan			3
TDR loans, Pre-modification Recorded Investment			$ 1,093
TDR loans, Post-modification Recorded Investment			$ 1,093
Interest Only [Member] | Owner Occupied Commercial Real Estate [Member] | Health Care [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan			1
TDR loans, Pre-modification Recorded Investment			$ 95
TDR loans, Post-modification Recorded Investment			$ 95
Interest Only [Member] | Owner Occupied Commercial Real Estate [Member] | Veterinary Industry [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan				1
TDR loans, Pre-modification Recorded Investment				$ 8
TDR loans, Post-modification Recorded Investment				$ 8
Extended Amortization [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan	2		2	2
TDR loans, Pre-modification Recorded Investment	$ 322		$ 322	$ 379
TDR loans, Post-modification Recorded Investment	$ 313		$ 313	$ 367
Extended Amortization [Member] | Commercial & Industrial [Member] | Independent Pharmacies [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan	2		2	2
TDR loans, Pre-modification Recorded Investment	$ 322		$ 322	$ 379
TDR loans, Post-modification Recorded Investment	$ 313		$ 313	$ 367
Payment Deferral [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan		1		4
TDR loans, Pre-modification Recorded Investment		$ 353		$ 572
TDR loans, Post-modification Recorded Investment		$ 217		$ 433
Payment Deferral [Member] | Commercial & Industrial [Member] | Veterinary Industry [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan				3
TDR loans, Pre-modification Recorded Investment				$ 219
TDR loans, Post-modification Recorded Investment				$ 216
Payment Deferral [Member] | Owner Occupied Commercial Real Estate [Member] | Death Care Management [Member]
Financing Receivable, Modifications [Line Items]
Number of TDR Loans | SecurityLoan		1		1
TDR loans, Pre-modification Recorded Investment		$ 353		$ 353
TDR loans, Post-modification Recorded Investment		$ 217		$ 217

Servicing Assets - Additional I

Servicing Assets - Additional Information (Detail) - USD ($) $ in Millions	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Dec. 31, 2014
Servicing Assets at Fair Value [Line Items]
Unpaid principal balances of loan serviced for others	$ 1,790		$ 1,470
Minimum [Member]
Servicing Assets at Fair Value [Line Items]
Fair value of servicing rights, discount rates	9.23%	6.45%
Fair value of servicing rights, prepayment rates	4.05%	1.89%
Maximum [Member]
Servicing Assets at Fair Value [Line Items]
Fair value of servicing rights, discount rates	13.52%	12.52%
Fair value of servicing rights, prepayment rates	9.90%	9.24%

Servicing Assets - Summary of A

Servicing Assets - Summary of Activity Pertaining to Servicing Rights (Detail) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015		Sep. 30, 2014
Servicing Asset at Fair Value, Amount [Roll Forward]
Balance at beginning of period	$ 39,983	$ 33,181	$ 34,999	[1]	$ 29,053
Additions, net	3,613	2,902	10,322		7,653
Changes in fair value	(3,006)	(984)	(4,731)		(1,607)
Balance at end of period	$ 40,590	$ 35,099	$ 40,590		$ 35,099
[1]	Derived from audited consolidated financial statements.

Borrowings - Schedule of Total

Borrowings - Schedule of Total Outstanding Short and Long-Term Borrowings (Detail) - USD ($)		Sep. 30, 2015	Dec. 31, 2014		Dec. 14, 2014	Sep. 18, 2014	May. 12, 2014	Apr. 30, 2011
Short term borrowings
Total short term borrowings	[1]		$ 6,100,000
Long term borrowings
Total long term borrowings		$ 42,079,000	41,849,000	[1]
Small Business Lending Fund Program [Member]
Long term borrowings
Line of credit		6,800,000	6,800,000					$ 6,800,000
Promissory Note [Member] | Independence Aviation LLC [Member]
Long term borrowings
Notes payable		5,631,000	5,842,000				$ 6,000,000
Construction Line of Credit [Member] | Tiburon Drive [Member]
Long term borrowings
Line of credit		24,000,000	16,914,000
Notes Payable to Banks [Member] | Revolving Credit Facility [Member]
Long term borrowings
Line of credit		0	5,000,000		$ 5,000,000
Notes Payable to Banks [Member] | Live Oak Banking Company [Member]
Long term borrowings
Line of credit			7,210,000
Loans Payable [Member] | Independence Aviation LLC [Member]
Long term borrowings
Line of credit		1,173,000
Secured Borrowing [Member]
Long term borrowings
Line of credit		$ 4,475,000
Gls Partner Notes payable [Member] | GLS Partner [Member]
Long term borrowings
Line of credit facility, amount used for acquisition			83,000
Line of Credit [Member]
Short term borrowings
Total short term borrowings			$ 6,100,000			$ 6,100,000
[1]	Derived from audited consolidated financial statements.

Borrowings - Schedule of Tota51

Borrowings - Schedule of Total Outstanding Short and Long-Term Borrowings (Parenthetical) (Detail)

Mar. 10, 2015USD ($)

Feb. 23, 2015USD ($)RelatedParty

Sep. 18, 2014USD ($)shares

Sep. 11, 2014USD ($)

Aug. 01, 2014USD ($)

May. 12, 2014USD ($)

Sep. 01, 2013USD ($)

Apr. 30, 2011USD ($)

Sep. 30, 2015USD ($)

Dec. 31, 2014USD ($)

Dec. 14, 2014USD ($)

Debt Instrument [Line Items]

Total short term borrowings

[1]

$ 6,100,000

Total short term borrowings

[1]

6,100,000

Secured Borrowing [Member]

Debt Instrument [Line Items]

Number of related parties transferred | RelatedParty

2

Line of credit

$ 4,475,000

Exchange amount of related party transaction

$ 4,700,000

Interest rate

4.25%

Line of credit facility description

prime plus 1%

Debt instrument term

60 months

Debt instrument, maturity date

Oct. 5, 2019

Fair value of pledged collateral securities

$ 4,500,000

Live Oak Banking Company [Member] | Notes Payable to Banks [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing capacity

$ 15,000,000

Line of credit

7,210,000

Line of credit secured by common stock, percentage

100.00%

Line of credit facility, interest rate description

LIBOR plus 4.00%

Debt instrument term

36 months

Debt instrument, maturity date

Aug. 1, 2017

GLS Partner [Member] | Gls Partner Notes payable [Member]

Debt Instrument [Line Items]

Line of credit, current

$ 250,000

Debt instrument term

24 months

Line of credit facility, periodic payment

$ 10,000

Tiburon Drive [Member] | Construction Line of Credit [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing capacity

$ 24,000,000

Debt instrument, offered date

Sep. 11, 2016

Line of credit

$ 24,000,000

16,914,000

Debt instrument, fixed interest rate

3.95%

Debt instrument term

84 months

Line of credit facility, monthly principal and interest payments, beginning date

Oct. 31, 2016

Principal and accrued interest payments

$ 146,000

Debt instrument, maturity date

Sep. 11, 2021

Remaining available credit facility

$ 0

Line of Credit [Member]

Debt Instrument [Line Items]

Total short term borrowings

$ 6,100,000

6,100,000

Debt instrument, offered date

Sep. 18, 2015

Total short term borrowings

$ 6,100,000

$ 6,100,000

Line of credit secured by common stock | shares

1,900,000

Debt instrument, interest rate effective percentage

0.16%

Debt instrument term

12 months

Debt instrument, maturity date

Feb. 23, 2015

Line of Credit [Member] | London Interbank Offered Rate (LIBOR) [Member]

Debt Instrument [Line Items]

Debt instrument, interest accrual period

30 days

Debt instrument, basis spread

3.50%

Independence Aviation LLC [Member] | Promissory Note [Member]

Debt Instrument [Line Items]

Notes payable

$ 6,000,000

$ 5,631,000

$ 5,842,000

Debt instrument, fixed interest rate

4.97%

Debt instrument term

59 months

Debt instrument, periodic payments

$ 48,000

Debt instrument, maturity date

May 12, 2019

Independence Aviation LLC [Member] | Loans Payable [Member]

Debt Instrument [Line Items]

Debt instrument, face amount

$ 1,200,000

Line of credit

$ 1,173,000

Debt instrument, fixed interest rate

4.96%

Debt instrument term

51 months

Line of credit facility, periodic payment

$ 9,000

Debt instrument, maturity date

Jun. 10, 2019

Revolving Credit Facility [Member] | Notes Payable to Banks [Member]

Debt Instrument [Line Items]

Line of credit, maximum borrowing capacity

$ 8,100,000

Line of credit

$ 0

5,000,000

$ 5,000,000

Interest rate

3.693%

Line of credit facility, interest rate description

LIBOR plus 3.50%

Debt instrument term

36 months

Debt instrument, maturity date

Sep. 18, 2017

Available credit facility

$ 8,100,000

Small Business Lending Fund Program [Member]

Debt Instrument [Line Items]

Line of credit

$ 6,800,000

$ 6,800,000

$ 6,800,000

Debt instrument, interest rate effective percentage range, minimum

1.50%

Debt instrument, interest rate effective percentage range, maximum

10.80%

Debt instrument, interest rate effective percentage

1.50%

Debt instrument, maturity date

Sep. 13, 2021

Small Business Lending Fund Program [Member] | Minimum [Member]

Debt Instrument [Line Items]

Debt instrument, partial interest rate

25.00%

[1]

Derived from audited consolidated financial statements.

Fair Value of Financial Instr52

Fair Value of Financial Instruments - Additional Information (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015	Mar. 31, 2015	Dec. 31, 2014	[1]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment at current market value	$ 51,628			$ 49,318
Investment transferred from Level 1 to Level 2		$ 1,900
Mutual Fund [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Investment at current market value	$ 1,949		$ 1,900
[1]	Derived from audited consolidated financial statements.

Fair Value of Financial Instr53

Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on Recurring Basis (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014		Sep. 30, 2014	Jun. 30, 2014	Dec. 31, 2013
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	$ 40,590	$ 39,983	$ 34,999	[1]	$ 35,099	$ 33,181	$ 29,053
Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	40,590		34,999
Recurring Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	40,590		34,999
Total assets at fair value	92,218		84,317
Recurring Fair Value [Member] | US Government Agencies [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	27,213		35,309
Recurring Fair Value [Member] | Residential Mortgage Backed Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	22,466		14,009
Recurring Fair Value [Member] | Mutual Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	1,949
Recurring Fair Value [Member] | Level 2 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Total assets at fair value	51,628		49,318
Recurring Fair Value [Member] | Level 2 [Member] | US Government Agencies [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	27,213		35,309
Recurring Fair Value [Member] | Level 2 [Member] | Residential Mortgage Backed Securities [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	22,466		14,009
Recurring Fair Value [Member] | Level 2 [Member] | Mutual Fund [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Investment securities available-for-sale	1,949
Recurring Fair Value [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Servicing assets	40,590		34,999
Total assets at fair value	$ 40,590		$ 34,999
[1]	Derived from audited consolidated financial statements.

Fair Value of Financial Instr54

Fair Value of Financial Instruments - Assets and Liabilities Measured at Fair Value on Non-recurring Basis (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	$ 24,988	$ 25,002
Foreclosed assets	48	371	[1]
Non-recurring Fair Value [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	22,224	24,016
Foreclosed assets	48	371
Total assets at fair value	22,272	24,387
Non-recurring Fair Value [Member] | Level 3 [Member]
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Impaired loans	22,224	24,016
Foreclosed assets	48	371
Total assets at fair value	$ 22,272	$ 24,387
[1]	Derived from audited consolidated financial statements.

Fair Value of Financial Instr55

Fair Value of Financial Instruments - Unobservable Inputs Used in Level 3 Assets and Liabilities Measured at Fair Value on Recurring or Non-recurring Basis (Detail) - Level 3 [Member] - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2015	Dec. 31, 2014
Impaired Loans [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 22,224	$ 24,016
Valuation Technique	Discounted appraisals Discounted expected cash flows
Unobservable Inputs	Appraisal adjustments Interest rate & repayment term
Impaired Loans [Member] | Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	10.00%	10.00%
Impaired Loans [Member] | Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	20.00%	20.00%
Impaired Loans [Member] | Weighted Average [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	5.97%	4.88%
Foreclosed Assets [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair Value	$ 48	$ 371
Valuation Technique	Discounted appraisals
Unobservable Inputs	Appraisal adjustments
Foreclosed Assets [Member] | Minimum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	10.00%	10.00%
Foreclosed Assets [Member] | Maximum [Member]
Fair Value Measurements, Recurring and Nonrecurring, Valuation Techniques [Line Items]
Fair value inputs discount rate range	20.00%	20.00%

Fair Value of Financial Instr56

Fair Value of Financial Instruments - Carrying Amount and Estimated Fair Value of Financial Instruments (Detail) - USD ($) $ in Thousands		Sep. 30, 2015	Jun. 30, 2015	Dec. 31, 2014		Sep. 30, 2014	Jun. 30, 2014	Dec. 31, 2013
Financial assets
Cash and due from banks, Carrying Amount		$ 129,881		$ 29,902	[1]	$ 38,642		$ 37,244
Cash and due from banks, Fair Value		129,881		29,902
Certificates of deposit with other banks, Carrying Amount		10,000		10,000	[1]
Certificates of deposit with other banks, Fair Value		9,984		9,861
Investment securities, available-for-sale		51,628		49,318	[1]
Loans held for sale, Carrying Amount		443,871		295,180	[1]
Loans held for sale, Fair Value		458,780		304,504
Loans, net of allowance for loan losses, Carrying Amount		253,399		199,529	[1]
Loans, net of allowance for loan losses, Fair Value		247,906		194,007
Servicing assets		40,590	$ 39,983	34,999	[1]	$ 35,099	$ 33,181	$ 29,053
Accrued interest receivable, Carrying Amount		4,841		3,059
Accrued interest receivable, Fair Value		4,841		3,059
Financial liabilities
Deposits, Carrying Amount		762,628		522,080	[1]
Deposits, Fair Value		754,715		522,058
Accrued interest payable, Carrying Amount		243		190
Accrued interest payable, Fair Value		243		190
Short term borrowings, Carrying Amount	[1]			6,100
Short term borrowings, Fair Value				6,100
Long term borrowings, Carrying Amount		42,079		41,849	[1]
Long term borrowings, Fair Value		44,987		44,738
Level 1 [Member]
Financial assets
Cash and due from banks, Fair Value		129,881		29,902
Certificates of deposit with other banks, Fair Value		9,984		9,861
Accrued interest receivable, Fair Value		4,841		3,059
Financial liabilities
Accrued interest payable, Fair Value		243		190
Level 2 [Member]
Financial assets
Investment securities, available-for-sale		51,628		49,318
Financial liabilities
Deposits, Fair Value		754,715		522,058
Level 3 [Member]
Financial assets
Loans held for sale, Fair Value		458,780		304,504
Loans, net of allowance for loan losses, Fair Value		247,906		194,007
Servicing assets		40,590		34,999
Financial liabilities
Short term borrowings, Fair Value				6,100
Long term borrowings, Fair Value		$ 44,987		$ 44,738
[1]	Derived from audited consolidated financial statements.

Commitments and Contingencies -

Commitments and Contingencies - Schedule of Commitments (Detail) - USD ($) $ in Thousands	Sep. 30, 2015	Dec. 31, 2014
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	$ 748,309	$ 538,401
Commitments to Extend Credit [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	747,909	537,951
Short-term Debt [Member] | Plexus Capital - Fund II Investment Commitment [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	100	100
Short-term Debt [Member] | Plexus Capital - Fund III Investment Commitment [Member]
Fair Value, Off-balance Sheet Risks, Disclosure Information [Line Items]
Total unfunded off-balance sheet credit risk	$ 300	$ 350

Commitments and Contingencies58

Commitments and Contingencies - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2015USD ($)
Commitment And Contingencies [Line Items]
Commitment letters expiration period	90 days
Maximum retained credit exposure	$ 2,000,000
Retained credit exposure	2,800,000
Standby Letters of Credit [Member]
Commitment And Contingencies [Line Items]
Standby letters of credit	$ 0

Stock Plans - Additional Inform

Stock Plans - Additional Information (Detail) - USD ($) $ in Thousands	Mar. 20, 2015	Sep. 30, 2015	Sep. 30, 2014	Sep. 30, 2015	Sep. 30, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock option based compensation expense		$ 431	$ 33	$ 726	$ 112
Intrinsic value of options exercised				$ 392	771
Risk free interest rate				1.96%
Expected dividend yield				1.00%
Expected volatility				43.38%
Restricted stock expense (credit)		67	$ (19)	$ 83	$ 143
Minimum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected average life				4 years
Maximum [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Expected average life				7 years
Stock Options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs, stock options		13,100		$ 13,100
Unrecognized compensation costs period recognized				7 years
Restricted Stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation costs period recognized				3 years 9 months
Unrecognized compensation costs		$ 959		$ 959
2015 Omnibus Plan [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of common voting shares authorized	4,300,000
Expiration date	Mar. 20, 2025
Options or restricted shares of expiration period	10 years
Percentage of fair market value of common stock	100.00%
Option vesting period	3 years

Stock Plans - Summary of Stock

Stock Plans - Summary of Stock Option Activity (Detail) - USD ($)	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Shares, Outstanding, Beginning balance	1,737,570	225,000
Shares, Exercised	47,570	191,660
Shares, Forfeited	192,671	170,590
Shares, Granted	1,829,748	1,874,820
Shares, Outstanding, Ending balance	3,327,077	1,737,570
Shares, Exercisable	158,950	22,227
Weighted Average Exercise Price, Outstanding, Beginning balance	$ 5.51	$ 1.01
Weighted Average Exercise Price, Exercised	4.52	0.92
Weighted Average Exercise Price, Forfeited	8.38	4.40
Weighted Average Exercise Price, Granted	15.52	5.48
Weighted Average Exercise Price, Outstanding, Ending balance	10.86	5.51
Weighted Average Exercise Price, Exercisable	$ 4.65	$ 1.52
Weighted Average Remaining Contractual Term, Outstanding	9 years 1 month 28 days	9 years 6 months 15 days
Weighted Average Remaining Contractual Term, Exercisable	8 years 18 days	7 years 15 days
Aggregate Intrinsic Value, Outstanding, Ending balance	$ 29,197,309	$ 8,902,969
Aggregate Intrinsic Value, Exercisable	$ 2,382,744	$ 202,486

Stock Plans - Summary of Non-ve

Stock Plans - Summary of Non-vested Stock Option Activity (Detail) - $ / shares	9 Months Ended
	Sep. 30, 2015	Sep. 30, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Shares, Non-vested, Beginning balance	1,704,230	91,754
Shares, Granted	1,829,748	1,874,820
Shares, Vested	173,180	80,641
Shares, Forfeited	192,671	170,590
Shares, Non-vested, Ending balance	3,168,127	1,715,343
Weighted Average Grant Date Fair Value, Non-vested, Beginning balance	$ 1.18	$ 0.44
Weighted Average Grant Date Fair Value, Granted	6.79	1.13
Weighted Average Grant Date Fair Value, Vested	0.97	0.44
Weighted Average Grant Date Fair Value, Forfeited	2.63	0.58
Weighted Average Grant Date Fair Value, Non-vested, Ending balance	$ 4.35	$ 1.18

Stock Plans - Summary of Restri

Stock Plans - Summary of Restricted Stock Activity (Detail) - Restricted Stock [Member]	9 Months Ended
	Sep. 30, 2015$ / sharesshares
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, Granted | shares	65,122
Shares, Vested | shares	0
Shares, Exercised | shares	0
Shares, Forfeited | shares	607
Shares, Non-vested | shares	64,515
Weighted Average Grant Date Fair Value, Outstanding, Beginning balance	$ 0
Weighted Average Grant Date Fair Value, Granted	16.10
Weighted Average Grant Date Fair Value, Vested	0
Weighted Average Grant Date Fair Value, Exercised	0
Weighted Average Grant Date Fair Value, Forfeited	10.63
Weighted Average Grant Date Fair Value, Non-vested	$ 16.15